LaunchRobotic Connective Network
Nightfood
Nightfood Holdings Inc. (OTCQB: NGTF), operating under the TechForce Robotics brand, is engineering a solution to this problem with a proprietary Robotic Connective Network and…
Robotics
The Durham edition · 2026
Durham · Photo: Wikimedia Commons (CC BY 4.0)Life sciencescompanies in Durham
Life sciences tech, genomics, oncology, infectious diseases, medical devices and more: the companies building life sciences in Durham, North Carolina, with their founders, funding, team size and business models.
146 company profiles69 with recorded fundingNovember 2026 edition
Recent life sciences business events in the United States
Funding, M&A, contract wins and launches involving 27,407 life sciences companies in the United States, last 24 months: 1641 M&A deals · 1543 funding rounds · 557 Contracts · 73 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jul 2026.
ContractInfrastructure
Sharp · client: Kddi
Electronics company Sharp is working with telco KDDI to build what it claims will be Asia's largest AI data center on the site of a former LCD screen manufacturing plant in Osaka, Japan.
AI data center
M&AAcquisition · Completed
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. acquires Mineralys therapeutics
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. acquired a new stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) during the fourth quarter, according to its…
Clinical-stage biopharmaceutical
M&AMerger · Announced
Ignite acquires Ignite Proteomics
The transaction values Ignite at an implied equity value of approximately $150 million, subject to the terms and conditions of the business combination agreement.
Functional proteomics
ContractTechnology
Chai Discovery · client: Pfizer
Pfizer announced a licensing agreement with Chai Discovery that gives it early access to the new Chai-3 AI platform, which could improve its ability to identify and design new drug…
Biopharmaceutical
FundingSenior Notes
IQVIA
IQVIA Holdings Inc. ('IQVIA') (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the 'Issuer'), priced an offering of €950,000,000 in aggregate principal amount of…
ContractSupply
Beijing mabworks biotech · client: Everest medicines
Everest Medicines announced that it has entered into a commercialization license agreement with Beijing Mabworks Biotech Co., Ltd. under which the Company has obtained exclusive rights…
Pharmaceutical
FundingSeries B
Advanced nanotherapies
Advanced NanoTherapies (ANT) has successfully closed a significant Series B funding round, garnering over $31 million.
Investors S3 Ventures, T45 Fund
Medical device
FundingRegistered Direct Offering
Lixte Biotechnology Holdings
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced definitive agreements with accredited investors for a registered direct offering expected to generate approximately $16.6 million in…
Investors Accredited investors
Pharmaceutical
ContractService
Hollister-Stier Laboratories LLC · client: Biomarin pharmaceutical
Hollister-Stier has agreed to filter and package an enzyme-replacement product for BioMarin Pharmaceutical Inc., of Novato, Calif.
Pharmaceutical
M&AAcquisition · Announced
Resmed acquires Noctrix health
announces that portfolio company Noctrix Health has been acquired by ResMed (NYSE: RMD), a global leader in sleep health and respiratory care, in a transaction valued at $340 million.
Medical technology
M&AMerger · Completed
B&C Telephone Inc. acquires Intouch solutions
B&C Telephone Inc., a Spokane-based company that sells and services commercial telephone systems, has merged with inTouch Solutions, a Boise-based telecommunication company.
Telecommunications
M&AAcquisition · Announced
The clorox company acquires Nutranext
Clorox will pay $700 million to acquire Nutranext, with the purchase price representing about 3.5 times calendar year 2017 sales.
Dietary and Nutritional Supplements
ContractService
Stellantis · client: Evera
With this agreement, Evera aims to rent 2,000 electric vehicles reconditioned by the Stellantis group by the end of 2027.
FundingMinority Stake Investment
Omniactive health technologies
Everstone Group has invested $35 million in a stake of Mumbai-based OmniActive Health Technologies Ltd.
Investors Everstone group
Nutraceutical
M&AAcquisition · Announced
Butterfly acquires Orgain
Butterfly, a LA-based private equity firm specializing in the food sector, has signed a definitive agreement to acquire a majority stake in Orgain, Inc., according to a press release.
Organic and clean nutrition products
FundingSeries B
Triomics
Triomics has raised USD $22 million in Series B funding in a round led by Battery Ventures.
Cancer-focused artificial intelligence
FundingUnderwritten Offering
Mineralys therapeutics
The aggregate gross proceeds to Mineralys from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be…
Biopharmaceutical
M&AAcquisition · Pending
Medtronic acquires Spr therapeutics
is currently finalizing the purchase of SPR Therapeutics
Medical device manufacturer
FundingPublic Offering
Avalo therapeutics
In first place was Avalo Therapeutics, which priced a $375 million public offering to advance the clinical development of its candidate abdakibart, including through its phase 3 topline…
Investors Na
Biotech
FundingPublic Offering
Editas medicine
In second place, gene editing company Editas Medicine announced a public offering of up to $319.4 million.
Investors Na
Biotech
FundingSeries A
Endra
Stockholm-based AI startup Endra has raised $50 million in Series A funding to scale its platform that automates design work for mechanical, electrical, and plumbing (MEP) consultants.…
AI
M&AAcquisition · Announced
Tend health acquires The doctors
Green Cross Health surged by more than a third after it agreed to sell its medical arm, The Doctors, to iwi-backed digital-first health firm Tend Health for $270 million.
Healthcare
LaunchVOXLS 20 C 225
Nikon Corporation
Nikon Corporation has launched the VOXLS 20 C 225, the latest addition to its VOXLS X-ray CT product lineup.
X-ray CT
FundingPublic Offering
Nrx pharmaceuticals
NRx Pharmaceuticals, Inc. today announced that it intends to offer shares of its common stock in an underwritten public offering with BTIG, LLC acting as the lead bookrunner and Lucid…
Biopharmaceutical
FundingNon-dilutive Capital
Apogee therapeutics
Apogee Therapeutics secured up to $1.3 billion in flexible, non-dilutive capital last month from Blackstone Life Sciences, including up to $800 million in synthetic royalty and access to…
Investors Blackstone Life Sciences
Biotech
FundingPublic Offering
Artiva biotherapeutics
It's also worth noting that Artiva Biotherapeutics wasn't far behind in fourth place after pricing a $300 million underwritten offering.
Investors Na
Biotech
M&AAcquisition · Announced
Rallybio acquires Avenzo therapeutics
Shares of Rallybio Corporation (RLYB) are gaining around 19 percent in Monday morning trading after the company announced an agreement to acquire Avenzo Therapeutics, Inc. through a…
Biotech
M&AMerger · Announced
Avenzo therapeutics acquires Rallybio
NEW YORK – Rallybio will merge with Avenzo Therapeutics to develop several precision oncology assets, including CDK2 and CDK4 inhibitors and bispecific antibody-drug conjugates (ADCs).
Oncology
M&AAcquisition · Announced
Dragos acquires Phosphorus
Dragos has acquired Phosphorus, broadening its reach across connected devices in operational environments.
Cybersecurity / device discovery and remediation software
Life sciences companies in Durham, by funding and team
Few life sciences companies in Durham, North Carolina publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 146 active companies.
Developer of therapeutics for eosinophilic asthma
PulmonologyUS$435.00mSeries A · Feb 2024
10LinkedIn · Jul 2026
E-commerce - product / Physical commerce
4 yr2022
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 19
- Recorded funding
- US$435.00m · Series A · Feb 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Drugs, Copd and asthma, Asthma
Funding over time
US$435.00m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Jorge BartolomeCEO
- Highest education
- Duke University
Investors · 10
Google VenturesFund
Marshall WaceFund
Maverick CapitalFund
- SanofiFund
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers2,338
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of human tissue-based products for vascular disease
Regenerative medicineUS$424.76mSeries D · Jun 2018
159+71% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
22 yr2004
0none in 3 months · last posted Mar 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 70
- Recorded funding
- US$424.76m · Series D · Jun 2018
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Diversified, Drugs
Funding over time
US$424.76m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Juliana BlumCo-Founder, Executive Advisor
Investors · 7
Bangkok BankFund
Pacific EagleFund
Reignwood GroupFund- Brady DouganAngel
Team & hiring signals
LinkedIn headcount159201-500
LinkedIn followers16,756
Earlier recorded team702022, a different source
Open roles1of 3 tracked · last posted Mar 2026
Patents
Patent filings137
Focus: Engineered vascular grafts and medicated implantable matrices for blood vessel replacement.
CPC C12N5/0068, A61F2/20, A61L27/3633Technology
AWS
PHP
MySQL
Nginx
WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of gene therapies for the treatment of ocular diseases
OphthalmologyUS$238.00mSeries C · Mar 2025
49-53% vs previous recordLinkedIn · Jul 2026
Fee-for-service
6 yr2020
0none in 3 months · last posted Jun 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 23 (previous snapshot 49)
- Recorded funding
- US$238.00m · Series C · Mar 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series C
- Focus
- Drugs, Retinal disorders
Funding over time
US$238.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Shannon BoyeFounder & Director
- Highest education
- Doctorates in neuroscience · University Of Florida
Investors · 11
AbingworthFund
Team & hiring signals
LinkedIn headcount4911-50
LinkedIn followers13,782
Earlier recorded team232022, a different source
Open roles1of 8 tracked · last posted Jun 2026
Recent company signals
- Milestone first patient in Phase 3 pivotal cohort of the LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis (#XLRS) patient doses
Technology
- PHP
- MySQL
Cloudflare- WordPress
jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of services in the development of precision medicine tools for cancer treatment
GenomicsUS$191.06mSeries D · Nov 2019
96-14% 12 mo to Dec 2022LinkedIn · Oct 2026
Fee-for-service
13 yr2013
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 993
- Recorded funding
- US$191.06m · Series D · Nov 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$191.06m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Sizhen WangCo-Founder & CEO
- Highest education
- Master's of business administration in finance · Ecole Des Hautes Etudes Commerciales
Investors · 11
AlexandriaFund
CICCFund
Share CapitalFund
V Star CapitalFund
Team & hiring signals
LinkedIn headcount96501-1,000
LinkedIn followers1,189
Earlier recorded team9932022, a different source
Technology
- Nginx
Bootstrap- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of gene editing technology for climate-resilient, nutritious, and sustainable crops
GenomicsUS$155.00mSeries C · Sep 2024
115+3% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months · last posted Jun 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 163 (previous snapshot 158)
- Recorded funding
- US$155.00m · Series C · Sep 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Applied genomics, Agrigenomics, Farm inputs, Seeds
Funding over time
US$155.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom AdamsCEO
Investors · 6
Aliment CapitalFund
DeerfieldFund
Leaps by BayerFund
MonsantoFund
TemasekFund
Team & hiring signals
LinkedIn headcount11551-200
LinkedIn followers18,199
Open roles1of 1 tracked · last posted Jun 2026
- Internship: 2026 Summer Intern
Recent company signals
- Partnership Partnership with Pipewise
Technology
- Cloudflare
HubSpot
Webflow- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of gene editing therapies to treat rare genetic diseases
Gene therapyUS$135.65mSeries B · Jun 2018
100+8% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
20 yr2006
0none in 3 months · last posted Mar 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 236
- Recorded funding
- US$135.65m · Series B · Jun 2018
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$135.65m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Matthew KaneCEO
Investors · 20
Agent CapitalFund- Aliment CapitalFund
BaxterFund
CowenFund
Team & hiring signals
LinkedIn headcount10051-200
LinkedIn followers24,648
Earlier recorded team2362022, a different source
Open roles1of 1 tracked · last posted Mar 2026
Patents
Patent filings68
Focus: Precise gene editing tools for therapeutic targets and engineered cell therapies
CPC C12N9/22, A61K38/465, C07K14/7151Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics to treat cardiopulmonary diseases
Drug deliveryUS$126.60mSeries B · Nov 2023
17-6% vs previous recordrecorded
Fee-for-service
16 yr2010
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 17 (previous snapshot 18)
- Recorded funding
- US$126.60m · Series B · Nov 2023
- Founded
- 2010 · about 16 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Drug delivery, Inhaled
Funding over time
US$126.60m across 12 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John PattonFounder
Investors · 2
MolexFund
Molex VenturesFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of drug discovery and precision therapy platform for oncology
OncologyUS$116.26mSeries B · Apr 2025
10LinkedIn · Jul 2026
Subscription
7 yr2019
0none in 3 months · last posted Jul 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 72
- Recorded funding
- US$116.26m · Series B · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Funding over time
US$116.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Hans CleversCo-Founder
Investors · 14
- AlexandriaFund
Alix VenturesFund
- Duke UniversityFund
EQTFund
FPV VenturesFund
Felicis VenturesFund
Team & hiring signals
LinkedIn headcount1051-200
LinkedIn followers7,314
Open roles0of 2 tracked · last posted Jul 2025
Patents
Patent filings97
Focus: Microfluidic organoid droplet generation and component delivery for personalized medicine
CPC B01L3/502784, C12N5/0693, G01N33/5011Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of AAV based gene therapies for rare diseases
GenomicsUS$98.20mSeries B · Mar 2021
4+82% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
11 yr2015
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 109 (previous snapshot 120)
- Recorded funding
- US$98.20m · Series B · Mar 2021
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Enabling technologies, Technology platforms
Funding over time
US$98.20m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Aravind AsokanCo-Founder
- Highest education
- Virology · University Of North Carolina At Chapel Hill School Of Medicine
Mavis Agbandje-McKennaCo-Founder & Director
Patrick RitschelCo-Founder
- Highest education
- Bachelor's in mechanical engineering · University Of Illinois At Urbana - Champaign
Investors · 12
- AlexandriaFund
- Novo HoldingsFund
PontifaxFund
SareptaFund
Team & hiring signals
LinkedIn headcount451-200
LinkedIn followers5,067
Earlier recorded team1092022, a different source
Patents
Patent filings89
Focus: Recombinant AAV vector design, manufacturing, and gene‑therapy delivery platforms
CPC C12N15/86, C07K14/005, C07K14/47Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of diagnostic products for pediatrics
PediatricsUS$95.89mSeries C · Sep 2025
73+51% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
13 yr2013
0none in 3 months · last posted Nov 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 133
- Recorded funding
- US$95.89m · Series C · Sep 2025
- Founded
- 2013 · about 13 years old
- Stage
- Series C
- Focus
- In vitro diagnostic tests, Newborn genetic screening
Funding over time
US$95.89m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Richard WestCo-Founder & CEO
- Highest education
- Doctorates in management · Claremont Graduate University
Vamsee PamulaFounder and President, Board of Directors
Investors · 5
- Duke UniversityFund
Team & hiring signals
LinkedIn headcount7351-200
LinkedIn followers6,898
Earlier recorded team1332022, a different source
Open roles1of 1 tracked · last posted Nov 2025
Patents
Patent filings56
Focus: Rapid microfluidic PCR and point‑of‑care diagnostic platforms for biochemical assays
CPC G01N33/54366, B01L7/525, G01N33/4905Technology
React- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of rapid infusion system for critically ill patients
Hospital equipmentUS$65.98mSeries B · Mar 2025
61-6% vs previous recordLinkedIn · Jul 2026
Subscription
14 yr2012
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 33 (previous snapshot 35)
- Recorded funding
- US$65.98m · Series B · Mar 2025
- Founded
- 2012 · about 14 years old
- Stage
- Series B
- Focus
- Critical care, Infusion systems
Funding over time
US$65.98m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mark PiehlCo-Founder & CMO
- Highest education
- Medicine · University Of North Carolina At Chapel Hill School Of Medicine
Investors · 13
OSF HealthCareFund
Orlando HealthFund
WakeMedFund
WellStarFund
Team & hiring signals
LinkedIn headcount6111-50
LinkedIn followers8,431
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of viral vaccines and antibody drug conjugates for the treatment of cancer
ImmunotherapyUS$48.59mSeries B · Apr 2021
4+34% 12 mo to Dec 2021LinkedIn · Jul 2026
E-commerce - product / Physical commerce
12 yr2014
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 47 (previous snapshot 56)
- Recorded funding
- US$48.59m · Series B · Apr 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Viral
Funding over time
US$48.59m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Matthias GromeierFounder
Darell BignerFounder
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers3,393
Earlier recorded team472021, a different source
Patents
Patent filings7
Focus: Oncolytic chimeric poliovirus therapies for glioblastoma and intravesical bladder cancer treatment
CPC A61K35/768, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
A next-generation cell cycle control company advancing precision treatments for cancer
ImmunotherapyUS$46.25mSeries B · Apr 2026
13+0% vs previous recordLinkedIn · Jul 2026
Physical commerce
6 yr2020
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 6 (previous snapshot 6)
- Recorded funding
- US$46.25m · Series B · Apr 2026
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$46.25m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 4
Patrick RobertsCo-Founder & CEO
- Highest education
- The University of North Carolina
Jay StrumCo-Founder
- Highest education
- PhD · Wake Forest University
John BisiCo-Founder
- Highest education
- Bachelor's of Science · NC State University
Fred EshelmanCo-Founder
Investors · 7
- Boxer CapitalFund
LillyFund
- PharmacosmosFund
Team & hiring signals
LinkedIn headcount132-10
LinkedIn followers1,691
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Manufacturer of cytokine agents for treating cancer
ImmunotherapyUS$45.00mSeries A · Nov 2020
47+34% 12 mo to Dec 2021recorded Dec 2021
Fee-for-service
7 yr2019
0none in 3 months
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 47 (previous snapshot 47)
- Recorded funding
- US$45.00m · Series A · Nov 2020
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Leadership · 1
Charles NicoletteCEO
Investors · 1
- Lucio RovatiAngel
Patents
Patent filings55
Focus: Patents concentrated in chemistry & materials
CPC C12N5/0639, G01N33/56972, C12N9/0002Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Affordable prescription drugs online, bridging the gap for US customers
OncologyUS$42.10mSeries D · Jul 2017
1-10% 12 mo to Dec 2022LinkedIn · Jul 2026
Physical commerce
12 yr2014
0none in 3 months
ConsumerSocial impact
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 19
- Recorded funding
- US$42.10m · Series D · Jul 2017
- Founded
- 2014 · about 12 years old
- Stage
- Series D
- Focus
- Drugs, Pan cancer
Funding over time
US$42.10m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Fred EshelmanCEO
Investors · 6
Lilly VenturesFund
- Fred EshelmanAngel
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers341
Earlier recorded team192022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutic products to treat brain injury in children
PediatricsUS$37.00mSeries A · Dec 2022
5-20% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
8 yr2018
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 8 (previous snapshot 10)
- Recorded funding
- US$37.00m · Series A · Dec 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, White matter brain injury
Funding over time
US$37.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Eric BennerCo-Founder
- Highest education
- Duke University School Of Medicine
Jason KralicCo-Founder
- Highest education
- Doctorates in neuroscience · University Of North Carolina At Chapel Hill School Of Medicine
Investors · 1
XontogenyFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers1,105
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of urological devices for post-prostatectomy
Genitourinary disordersUS$36.15mSeries B · Feb 2026
8LinkedIn · Jul 2026
Physical commerce / Subscription
5 yr2021
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 3 (previous snapshot 3)
- Recorded funding
- US$36.15m · Series B · Feb 2026
- Founded
- 2021 · about 5 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutics, Urinary incontinence
Funding over time
US$36.15m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Bruce ChoiFounder & CTO
- Highest education
- Master's of science in biomedical engineering · California Polytechnic State University - San Luis Obispo
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers1,183
Recent company signals
- Milestone first patient enrolled in the ARID II IDE pivotal trial
- Milestone 17th site to enroll a patient into the study patient enrollment site enrollment
- Milestone 16th site to enroll a patient into the study patient enrollment site enrollment
- Milestone 15th site to enroll a patient into the study patient enrollment site enrollment
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for neurodegenerative diseases
NeurologyUS$33.02mSeries B · Sep 2022
12-12% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
13 yr2013
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 14 (previous snapshot 16)
- Recorded funding
- US$33.02m · Series B · Sep 2022
- Founded
- 2013 · about 13 years old
- Stage
- Series B
- Focus
- Drugs, Neurodegenerative, Alzheimer disease
Funding over time
US$33.02m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John DidsburyFounder and CEO
Investors · 1
NIAFund
Team & hiring signals
LinkedIn headcount122-10
LinkedIn followers472
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of hemostasis and fluid replacement products
HematologyUS$30.45mSeries B · Jul 2022
12-20% 12 mo to Dec 2020LinkedIn · Jul 2026
Subscription
24 yr2002
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 4 (previous snapshot 12)
- Recorded funding
- US$30.45m · Series B · Jul 2022
- Founded
- 2002 · about 24 years old
- Stage
- Series B
- Focus
- Medical devices, Monitoring, Coagulation
Funding over time
US$30.45m across 9 disclosed equity rounds
Darker bars = larger roundsLeadership · 2
John MowellCEO - Chairman
Bert ValadaPresident and CEO
Team & hiring signals
LinkedIn headcount122-10
LinkedIn followers509
Earlier recorded team42020, a different source
Patents
Patent filings112
Focus: Hemostatic textiles and point‑of‑care coagulation monitoring devices for surgical bleeding control
CPC G01N33/86, A61L15/00, A61K9/1688Technology
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developing inhaled therapeutics for severe, chronic respiratory diseases
PulmonologyUS$29.12mSeries A · Oct 2018
10recorded
Physical commerce
13 yr2013
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 10
- Recorded funding
- US$29.12m · Series A · Oct 2018
- Founded
- 2013 · about 13 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Funding over time
US$29.12m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Robert Tarranex-Co-Founder
- Highest education
- PhD · Newcastle University
Investors · 3
5AM VenturesFund
CanaanFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of diagnostics for cancer classification and treatment
GenomicsUS$26.86mSeries C · Jun 2025
14-14% vs previous recordLinkedIn · Jul 2026
Subscription
15 yr2011
0none in 3 months
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 22)
- Recorded funding
- US$26.86m · Series C · Jun 2025
- Founded
- 2011 · about 15 years old
- Stage
- Series C
- Focus
- Applied genomics, Clinical genomics, Therapeutics, In-vitro diagnostic tests
Funding over time
US$26.86m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 5
- AlexandriaFund
LabCorpFund
Alexandria Venture InvestmentsFund
Team & hiring signals
LinkedIn headcount1411-50
LinkedIn followers2,216
Technology
- PHP
- MySQL
- Cloudflare
Salesforce- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of gene therapies to treat retinal degenerative diseases
Gene therapyUS$23.50mSeed · Jun 2023
46-55% vs previous recordLinkedIn · Oct 2026
Fee-for-service
5 yr2021
0none in 3 months · last posted Mar 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14 (previous snapshot 31)
- Recorded funding
- US$23.50m · Seed · Jun 2023
- Founded
- 2021 · about 5 years old
- Stage
- Public
- Focus
- Drugs, Retinal disorders
Funding over time
US$23.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jason MenzoCo-Founder
Investors · 3
Bios PartnersFund
RD FundFund
Team & hiring signals
LinkedIn headcount4611-50
LinkedIn followers9,127
Open roles1of 2 tracked · last posted Mar 2026
Patents
Patent filings26
Focus: Pharmaceutical eye‑drop formulations targeting mydriasis, presbyopia, and AMD treatment
CPC A61K31/417, A61K9/0048, C07C57/42Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of boron-based medicines for various disease conditions
Life sciences techUS$23.50mSeries A · Sep 2022
2LinkedIn · Jul 2026
Commission on transaction / E-commerce - product
5 yr2021
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, E-commerce - product, Subscription
- Team size
- Not available
- Recorded funding
- US$23.50m · Series A · Sep 2022
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Leadership · 1
Julie GrantCEO
- Highest education
- MBA · Stanford University
Team & hiring signals
LinkedIn headcount211-50
LinkedIn followers467
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a technology to isolate and recover single cells for molecular analysis
Life sciences platforms and toolsUS$19.10mSeries B · Aug 2023
21+4% vs previous recordLinkedIn · Jul 2026
Subscription
17 yr2009
0none in 3 months
HardwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 28 (previous snapshot 27)
- Recorded funding
- US$19.10m · Series B · Aug 2023
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Instruments, Cell biology, Cell sorting
Funding over time
US$19.10m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Gary PaceCEO
Investors · 2
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers2,101
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of hernia mesh devices for treating hernia
Genitourinary disordersUS$18.46mSeries A · Sep 2025
11+9% vs previous recordLinkedIn · Jul 2026
Physical commerce
11 yr2015
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 12 (previous snapshot 11)
- Recorded funding
- US$18.46m · Series A · Sep 2025
- Founded
- 2015 · about 11 years old
- Stage
- Series A
- Focus
- Medical devices, Therapeutics, Hernia
Funding over time
US$18.46m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Howard LevinsonFounder & CMO
Investors · 1
Team & hiring signals
LinkedIn headcount112-10
LinkedIn followers885
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for undruggable targets
Life sciences techUS$18.30mSeries A · Feb 2026
32+0% vs previous recordLinkedIn · Jul 2026
Physical commerce / Subscription
7 yr2019
0none in 3 months · last posted Nov 2025
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 10 (previous snapshot 10)
- Recorded funding
- US$18.30m · Series A · Feb 2026
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Funding over time
US$18.30m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 4
Mark HallenCo-Founder & CTO
- Highest education
- Bachelor's in mathematics · Duke University
Nancy Miller-RichCo-Founder
Marcel FrenkelCo-Founder & CEO
- Highest education
- Doctorates in biochemistry · Duke University
Bruce DonaldCo-Founder
- Highest education
- Computer Science · Massachusetts Institute Of Technology
Investors · 16
- AlexandriaFund
- Duke UniversityFund
IndieBioFund
Team & hiring signals
LinkedIn headcount3211-50
LinkedIn followers4,585
Open roles1of 1 tracked · last posted Nov 2025
- Hiring: Principal Scientific Engineer · Dublin, North Carolina
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of treatment for the treatment of inflammatory diseases
ImmunologyUS$16.02mSeries A · May 2022
5LinkedIn · Jul 2026
E-commerce - product / Physical commerce
10 yr2016
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 8
- Recorded funding
- US$16.02m · Series A · May 2022
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Drugs, Inflammatory diseases, Viral, Influenza
Funding over time
US$16.02m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Robin DeruyscherFounder
- Highest education
- BS · SUNY Oswego
Investors · 4
Team & hiring signals
LinkedIn headcount511-50
LinkedIn followers345
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developing 5-HTP drugs to amplify serotonin for mental illness treatment
NeurologyUS$14.85mSeries A · Sep 2025
6LinkedIn · Jul 2026
E-commerce - product / Physical commerce
13 yr2013
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 10
- Recorded funding
- US$14.85m · Series A · Sep 2025
- Founded
- 2013 · about 13 years old
- Stage
- Series A
- Focus
- Drugs, Psychiatric, Diversified
Funding over time
US$14.85m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Marc CaronCo-Founder
Jacob JacobsenCo-Founder
- Highest education
- Bachelor's in biology · Københavns Universitet - University Of Copenhagen
Team & hiring signals
LinkedIn headcount62-10
LinkedIn followers777
Technology
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of multiplexed protein quantification platform for clinical diagnostics and research
Life sciences platforms and toolsUS$13.00mSeries C · Mar 2025
15-45% vs previous recordLinkedIn · Jul 2026
Physical commerce
20 yr2006
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 11 (previous snapshot 20)
- Recorded funding
- US$13.00m · Series C · Mar 2025
- Founded
- 2006 · about 20 years old
- Stage
- Series C
- Focus
- In-vitro diagnostic tests, Women's cancer, Breast cancer
Funding over time
US$13.00m across 10 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David UreChairman & Founder
Investors · 1
South Dakota Equity PartnersFund
Team & hiring signals
LinkedIn headcount1511-50
LinkedIn followers583
Patents
Patent filings30
Focus: High-throughput immunoassay platforms for serology and cancer biomarker detection
CPC G01N33/557, G01N33/575, G01N33/57515Technology
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of polymer-based devices for localized low dose radiation therapy or brachytherapy
OncologyUS$12.40mSeries A · Nov 2021
5LinkedIn · Jul 2026
Physical commerce
20 yr2006
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 6
- Recorded funding
- US$12.40m · Series A · Nov 2021
- Founded
- 2006 · about 20 years old
- Stage
- Series A
- Focus
- Medical devices, Therapies, Radiation therapy, Brachytherapy
Funding over time
US$12.40m across 8 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Suzanne BabcockCEO
Team & hiring signals
LinkedIn headcount511-50
LinkedIn followers513
Patents
Patent filings23
Focus: Microencapsulated, bioabsorbable brachytherapy sources for precise internal radiation therapy
CPC A61N5/1001, A61M37/0069Technology
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a glaucoma drainage device
OphthalmologyUS$12.23mSeries A · Apr 2018
3LinkedIn · Jul 2026
E-commerce - product / Physical commerce
16 yr2010
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$12.23m · Series A · Apr 2018
- Founded
- 2010 · about 16 years old
- Stage
- Series A
- Focus
- Medical devices, Therapy, Glaucoma, Shunt
Funding over time
US$12.23m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Ray KraussCEO
Investors · 6
VCapitalFund
InFocus Capital PartnersFund
Pilot Mountain VenturesFund- Triangle Venture AllianceFund
Team & hiring signals
LinkedIn headcount32-10
LinkedIn followers153
Patents
Patent filings2
Focus: Glaucoma treatment devices for lowering intraocular pressure
CPC A61F9/00781Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a genome sequencing and amplification system
Life sciences platforms and toolsUS$11.50mSeed · Jan 2020
40+91% 12 mo to Dec 2021LinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21 (previous snapshot 59)
- Recorded funding
- US$11.50m · Seed · Jan 2020
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- Instruments, Genomics, Nucleic acid sequencing, Enabling technologies
Founders · 2
Jay WestCo-Founder & CEO
Charles GawadCo-Founder
- Highest education
- Doctorates in biology · Stanford University
Investors · 2
Anzu PartnersFund
Team & hiring signals
LinkedIn headcount4051-200
LinkedIn followers6,305
Earlier recorded team212021, a different source
Recent company signals
- Launch Launched ResolveOMETM Stability Buffer (SB) Reagent (single-cell or low-input multiomic chemistry sample collection and storage)
Patents
Patent filings8
Focus: High‑sensitivity nucleic‑acid amplification and single‑cell genomic analysis technologies
CPC C12Y207/07007, C12Q1/6806, C12Q1/70Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a platform for accelerated crop breeding and evolution
Crop techUS$11.25mSeries A · Mar 2025
30LinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months
Artificial Intelligence
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 10
- Recorded funding
- US$11.25m · Series A · Mar 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Farm inputs, Plant genetic testing, Applied genomics, Agrigenomics
Funding over time
US$11.25m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Brendan CollinsCo-Founder
Mariano AlvarezCo-Founder
- Highest education
- Bachelor's in biology · University Of South Florida
Investors · 11
- AlexandriaFund
At One VenturesFund
Better VenturesFund
Climate CapitalFund
Germin8 VenturesFund- IndieBioFund
SOSVFund
Team & hiring signals
LinkedIn headcount3011-50
LinkedIn followers4,779
Recent company signals
- Partnership Partnership with Seed to System
Patents
Patent filings14
Focus: AI-driven bioinformatics platforms for genomic, gene‑environment and spectral data analysis
CPC G16B20/00, G16B20/20, G06V10/25Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a predictive breeding platform to identify crop traits and build crop models
GenomicsUS$8.50mSeries A · Dec 2018
5+85% 12 mo to Dec 2021LinkedIn · Jul 2026
Physical commerce / Subscription
12 yr2014
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 24 (previous snapshot 17)
- Recorded funding
- US$8.50m · Series A · Dec 2018
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Farm inputs, Plant breeding, Management solutions, Analytics
Founders · 2
Spencer MaughanCo-Founder & Chairman
Philip BenfeyCo-Founder & Chairman
- Highest education
- Doctorates in biology · Harvard University
Investors · 7
GRO AllianceFund
KdT VenturesFund
S2G VenturesFund
Tom FarmsFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers516
Earlier recorded team242021, a different source
Patents
Patent filings37
Focus: Non‑invasive root phenotyping for agricultural plant imaging and phenomics
CPC G01N33/0098, C12Q1/6895, G01N21/84Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Mobile solutions for making behavioural changes
NeurologyUS$8.06mSeries A · Nov 2020
3LinkedIn · Jul 2026
Subscription
13 yr2013
—No postings tracked
ConsumerSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 7
- Recorded funding
- US$8.06m · Series A · Nov 2020
- Founded
- 2013 · about 13 years old
- Stage
- Series A
- Focus
- Value based care, Remote monitoring, Hardware, Other devices
Funding over time
US$8.06m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Mark WilliamsCEO
- Highest education
- Doctorates · Yale University
Team & hiring signals
LinkedIn headcount32-10
LinkedIn followers85
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of invitro platform for drug testing
Life sciences platforms and toolsUS$7.53mSeed · Mar 2025
29+12% vs previous recordLinkedIn · Jul 2026
Physical commerce
11 yr2015
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 29 (previous snapshot 26)
- Recorded funding
- US$7.53m · Seed · Mar 2025
- Founded
- 2015 · about 11 years old
- Stage
- Seed
- Focus
- Research assays, Cell based assays, Toxicity assays
Funding over time
US$7.53m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 5
Scott MagnessCo-Founder
- Highest education
- BS · University of California San Diego
Nancy AllbrittonCo-Founder
- Highest education
- BS · Louisiana State University
Michael BironCo-Founder & CEO
- Highest education
- MBA · UNC Kenan-Flagler Business School
Yuli WangCo-Founder & CSO
Christopher Sims MdFounder, Principle Investigator and Board Member
- Highest education
- Biology · Uc Irvine
Investors · 5
RTP CapitalFund
VentureSouthFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers7,485
Technology
- Cloudflare
- HubSpot
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of formulation technology for bio-therapeutics drug delivery
Life sciences techUS$7.26mSeries B · Mar 2024
24+33% 12 mo to Dec 2019LinkedIn · Jul 2026
Physical commerce
10 yr2016
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 4
- Recorded funding
- US$7.26m · Series B · Mar 2024
- Founded
- 2016 · about 10 years old
- Stage
- Series B
- Focus
- Research & development, Drug formulation
Funding over time
US$7.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Karen LeVertCo-Founder & CEO
- Highest education
- BS · Eastern Michigan University
Investors · 2
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers1,456
Earlier recorded team42019, a different source
Technology
Google Cloud- React
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of an augmented-reality-based surgical camera
Surgical instrumentsUS$6.91mSeries A · Sep 2022
11-35% vs previous recordrecorded
Subscription
12 yr2014
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 11 (previous snapshot 17)
- Recorded funding
- US$6.91m · Series A · Sep 2022
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Intraoperative blood salvage
Funding over time
US$6.91m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jim SundFounder & CEO
- Highest education
- Doctorates in computer engineering · Duke University
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
PCR-based Human and Animal testing for vector-borne diseases
Clinical genomicsUS$6.72mSeries A · Apr 2025
20-29% vs previous recordLinkedIn · Jul 2026
Subscription
17 yr2009
0none in 3 months
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15 (previous snapshot 21)
- Recorded funding
- US$6.72m · Series A · Apr 2025
- Founded
- 2009 · about 17 years old
- Stage
- Series A
- Focus
- In vitro diagnostic tests, Diversified, Applied genomics, Clinical genomics
Funding over time
US$6.72m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Amanda ElamPresident & CEO
- Highest education
- Doctorates, Sociology · University Of North Carolina At Chapel Hill
Team & hiring signals
LinkedIn headcount2011-50
LinkedIn followers2,132
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutic solutions for treating solid tumor brain metastasis
OncologyUS$6.50mSeries A · Jul 2018
—Not available
Subscription
9 yr2017
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$6.50m · Series A · Jul 2018
- Founded
- 2017 · about 9 years old
- Stage
- Series A
- Focus
- Drugs, Pan cancer
Founders · 2
Kimberly BlackwellCo-Founder
- Highest education
- Duke University
Michael ZalutskyCo-Founder
- Highest education
- Clark University
Investors · 1
Patents
Patent filings7
Focus: HER2-targeted binding molecules for cancer therapy
CPC C07K16/32Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutic antibodies
Life sciences platforms and toolsUS$6.45mSeries B · Dec 2020
4-33% vs previous recordLinkedIn · Jul 2026
Physical commerce
12 yr2014
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 4 (previous snapshot 6)
- Recorded funding
- US$6.45m · Series B · Dec 2020
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Immuno oncology, Research services
Funding over time
US$6.45m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Edward PatzCo-Founder & CEO
Investors · 4
- Duke UniversityFund
- Jeffery “TJ” HeymanAngel
- Paul FunkAngel
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers615
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of solutions for the treatment of orthopedic-related infections
OrthopedicsUS$5.09mSeed · May 2025
7LinkedIn · Jul 2026
E-commerce - product / Physical commerce
4 yr2022
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 5
- Recorded funding
- US$5.09m · Seed · May 2025
- Founded
- 2022 · about 4 years old
- Stage
- Seed
- Focus
- Medical devices, Therapies, Trauma fixation
Funding over time
US$5.09m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Jake DonovanCo-Founder and Head of Product Development
- Highest education
- Master's in management · Duke University
Ken GallCo-Founder
- Highest education
- PhD · University of Illinois
Team & hiring signals
LinkedIn headcount72-10
LinkedIn followers662
Patents
Patent filings3
Focus: Orthopedic intramedullary fixation devices with drug‑eluting coatings for bone healing
CPC A61B17/72, A61L27/44Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Develops assays and research tools for specific biological systems
Life sciences platforms and toolsUS$5.00mSeries B · Mar 2006
193+112% 12 mo to Dec 2022recorded Dec 2022
Physical commerce / Subscription
22 yr2004
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 193
- Recorded funding
- US$5.00m · Series B · Mar 2006
- Founded
- 2004 · about 22 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery
Funding over time
US$5.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Peyton AndersonFounder & CEO
- Highest education
- Master's of Business Administration · UNC Kenan-Flagler Business School
Investors · 4
NC IDEAFund
Trinity Healthcare DevelopmentFund
Patents
Patent filings97
Focus: Protein diagnostics, peptide-coated device drug delivery, and biomaterial tissue repair technologies.
CPC A61L27/227, A61K47/64, C07K14/001Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of data and result information for online lottery games
Life sciences platforms and toolsUS$5.00mSeed · Mar 2023
1-17% vs previous recordLinkedIn · Jul 2026
Physical commerce
7 yr2019
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 10 (previous snapshot 12)
- Recorded funding
- US$5.00m · Seed · Mar 2023
- Founded
- 2019 · about 7 years old
- Stage
- Seed
- Focus
- Research services, Diversified, Applied genomics, Agrigenomics
Funding over time
US$5.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
France AdilFounder & CEO
- Highest education
- Master's · Université Claude Bernard Lyon 1
Investors · 12
8090 IndustriesFund- AlexandriaFund
Cantos VenturesFund
Climate CapitalFund
PortfoliaFund
SFVFund
SeedFolioFund
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers4,424
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of protein-based biomaterials for tissue engineering and regenerative medicine
Regenerative medicineUS$4.77mSeed · Sep 2025
13LinkedIn · Jul 2026
Physical commerce
8 yr2018
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 6
- Recorded funding
- US$4.77m · Seed · Sep 2025
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- Medical devices, Therapeutic devices, Regenerative devices
Funding over time
US$4.77m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Stefan RobertsCo-Founder & CEO
- Highest education
- Doctorates in biomedical engineering · Duke University
Scott HollenbeckCo-Founder
Ashutosh ChilkotiCo-Founder & Chairman
Investors · 1
Y CombinatorFund
Team & hiring signals
LinkedIn headcount132-10
LinkedIn followers688
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of AI-powered platform for clinical research participant recruitment workflows
Life sciences techUS$4.30mSeed · Oct 2025
10LinkedIn · Jul 2026
Subscription
3 yr2023
—No postings tracked
Artificial IntelligenceSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$4.30m · Seed · Oct 2025
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Ctms and edc, Clinical trials, Cognitive ai, Conversational ai
Founders · 2
Saathvik BoompelliCo-Founder
- Highest education
- Duke University
John XuCo-Founder
Investors · 8
- Ali RowghaniAngel
- Christophe RimannAngel
- Jack AltmanAngel
- Joshua MillerAngel
- Max CohenAngel
- Sajith WickramasekaraAngel
- Trey HoltermanAngel
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers873
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of laboratory automation solutions for performing routine tasks in laboratories
Healthcare itUS$4.00mSeed · Aug 2022
18LinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21
- Recorded funding
- US$4.00m · Seed · Aug 2022
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- Research & development, Laboratory management, Laboratory automation, Pathology
Funding over time
US$4.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Jihoon BaekCo-Founder & CEO
- Highest education
- The University of North Carolina
George ZhaoFounder & COO / Head of Product
Investors · 2
Tweener FundFund
Team & hiring signals
LinkedIn headcount1811-50
LinkedIn followers1,873
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Revolutionizing surgical dissection with safer, faster, and precise technology
Surgical instrumentsUS$3.84mSeries A · Mar 2019
3recorded
Subscription
19 yr2007
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 3
- Recorded funding
- US$3.84m · Series A · Mar 2019
- Founded
- 2007 · about 19 years old
- Stage
- Series A
- Focus
- Cutting and ablating
Funding over time
US$3.84m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Hugh CrenshawCEO & Co-founder
Charles A. PellCSO & Co-Founder
- Highest education
- Master's of fine arts in fine arts · University Of Notre Dame
Investors · 1
Technology
- PHP
- MySQL
- Nginx
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider and manufacturer of fluorescent dyes for medical diagnostic and imaging systems and tests
Life sciences platforms and toolsUS$3.50mSeries A · May 2021
12+0% vs previous recordrecorded
Physical commerce
13 yr2013
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 12 (previous snapshot 12)
- Recorded funding
- US$3.50m · Series A · May 2021
- Founded
- 2013 · about 13 years old
- Stage
- Series A
- Focus
- Research reagents and kits, Probes and dyes, Dyes
Funding over time
US$3.50m across 4 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Russell ThomasCEO & President
- Highest education
- Master's · North Carolina State University
Investors · 1
ThreeD CapitalFund
Technology
- Nginx
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
AI-powered drug discovery and development transforming healthcare with generative AI
Life sciences techUS$3.35mSeries A · Jul 2015
5LinkedIn · Jul 2026
Fee-for-service
17 yr2009
—No postings tracked
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 5
- Recorded funding
- US$3.35m · Series A · Jul 2015
- Founded
- 2009 · about 17 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics
Funding over time
US$3.35m across 4 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Ed AddisonChairman & CEO
Team & hiring signals
LinkedIn headcount511-50
LinkedIn followers1,228
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
50 of 146 companies shown here · the full list is on Radar
Fliar Radar
Explore all 146 life sciences companies in Durham on Radar
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in Durham on Radar- Every company, not just 50All 146 life sciences companies in Durham, filterable by stage, funding, team size, revenue model and age.
- Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
- Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
- Save and exportBuild lists, compare companies side by side and export them from your Radar account.
Explore life sciences companies in Durham by what you are looking for
Find top life sciences companies in Durham across genomics, oncology, and drug development. Explore life sciences companies and life sciences jobs in Durham.
8 ways to explore life sciences in Durham
Life sciences technology companiesGenomics and gene therapy companiesOncology and cancer treatment companiesInfectious disease and immunology companiesMedical device and diagnostics companiesPublic life sciences companies in Durham
Life sciences technology companies
Technology companies supporting life sciences research and development.
- Precision BioSciencesSee in list
Developer of gene editing therapies to treat rare genetic diseases
Gene therapy - Reactive BiosciencesSee in list
Developer of boron-based medicines for various disease conditions
Life sciences tech - Ten63See in list
Developer of therapeutics for undruggable targets
Life sciences tech - InanovateSee in list
Provider of multiplexed protein quantification platform for clinical diagnostics and research
Life sciences platforms and tools - BioskrybSee in list
Developer of a genome sequencing and amplification system
Life sciences platforms and tools
37 companies in DurhamAll 2,222 life sciences tech companies in United States →
Genomics and gene therapy companies
Companies developing genomics, gene editing, and gene therapy applications.
- Atsena TherapeuticsSee in list
Developer of gene therapies for the treatment of ocular diseases
Ophthalmology - GenetronHealthSee in list
Provider of services in the development of precision medicine tools for cancer treatment
Genomics - PairwiseSee in list
Provider of gene editing technology for climate-resilient, nutritious, and sustainable crops
Genomics - XilisSee in list
Developer of drug discovery and precision therapy platform for oncology
Oncology - GeneCentricSee in list
Developer of diagnostics for cancer classification and treatment
Genomics
19 companies in DurhamAll 2,583 genomics companies in United States →
Oncology and cancer treatment companies
Life sciences companies developing oncology and cancer-focused therapies.
- Precision BioSciencesSee in list
Developer of gene editing therapies to treat rare genetic diseases
Gene therapy - XilisSee in list
Developer of drug discovery and precision therapy platform for oncology
Oncology - Istari OncologySee in list
Developer of viral vaccines and antibody drug conjugates for the treatment of cancer
Immunotherapy - Incyclix BioSee in list
A next-generation cell cycle control company advancing precision treatments for cancer
Immunotherapy - CoImmuneSee in list
Manufacturer of cytokine agents for treating cancer
Immunotherapy
32 companies in DurhamAll 2,665 oncology companies in United States →
Infectious disease and immunology companies
Companies researching treatments, diagnostics, and therapies for infectious diseases.
- Istari OncologySee in list
Developer of viral vaccines and antibody drug conjugates for the treatment of cancer
Immunotherapy - Emergo TherapeuticsSee in list
Developer of treatment for the treatment of inflammatory diseases
Immunology - Galaxy DiagnosticsSee in list
PCR-based Human and Animal testing for vector-borne diseases
Clinical genomics 
Cellective BioTherapyB Cell-Based Cellular Therapies for Immunomodulation, Immunodeficiency and Autoimmunity
Diversified pharmaceuticals
Global Lyme DiagnosticsDeveloper of diagnostics tests for Lyme disease
Infectious diseases
27 companies in DurhamAll 1,010 infectious diseases companies in United States →
Medical device and diagnostics companies
Companies developing medical devices, diagnostics, and clinical instruments.
- AeramiSee in list
Developer of therapeutics to treat cardiopulmonary diseases
Drug delivery - ReseluteSee in list
Developer of solutions for the treatment of orthopedic-related infections
Orthopedics - inSoma BioSee in list
Provider of protein-based biomaterials for tissue engineering and regenerative medicine
Regenerative medicine 
Akros MedicalA medical device for orthopedic surgery
Orthopedics
CytexOrthoDeveloper of bio-artificial devices to treat musculoskeletal diseases
Orthopedics
47 companies in DurhamAll 886 medical devices companies in United States →
Public life sciences companies in Durham
Life sciences companies in Durham that are publicly listed.
- HumacyteSee in list
Provider of human tissue-based products for vascular disease
Regenerative medicine - GenetronHealthSee in list
Provider of services in the development of precision medicine tools for cancer treatment
Genomics - Precision BioSciencesSee in list
Developer of gene editing therapies to treat rare genetic diseases
Gene therapy 
IQVIAProvider of clinical research and commercialization solutions for healthcare
Life sciences tech
BioventusManufacturer of healing therapy products
Orthopedics
8 companies in Durham
Life sciences startups in Durham
Recently founded life sciences companies in Durham.
- AreteiaSee in list
Developer of therapeutics for eosinophilic asthma
Pulmonology - Levee MedicalSee in list
Developer of urological devices for post-prostatectomy
Genitourinary disorders - Opus GeneticsSee in list
Developer of gene therapies to treat retinal degenerative diseases
Gene therapy - Reactive BiosciencesSee in list
Developer of boron-based medicines for various disease conditions
Life sciences tech - ReseluteSee in list
Developer of solutions for the treatment of orthopedic-related infections
Orthopedics
16 companies in Durham
Life sciences companies hiring in Durham
Life sciences companies in Durham with hiring activity.
- HumacyteSee in list
Provider of human tissue-based products for vascular disease
Regenerative medicine - Atsena TherapeuticsSee in list
Developer of gene therapies for the treatment of ocular diseases
Ophthalmology - PairwiseSee in list
Provider of gene editing technology for climate-resilient, nutritious, and sustainable crops
Genomics - XilisSee in list
Developer of drug discovery and precision therapy platform for oncology
Oncology - BaebiesSee in list
Provider of diagnostic products for pediatrics
Pediatrics
8 companies in Durham
Mobile reach
Top 5 life sciences apps from Durham
The most-installed Android apps published by life sciences companies headquartered in Durham — 120K installs between them. 5 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
1 of 5
Installs105K
Rating3.892K ratings
Installs, year on year+15%
Last updatedMay 2026
Legal entityIQVIA Holdings Inc.declared on Google Play
Installs10K
Rating2.941 ratings
Last updatedDec 2025
Legal entityBioventus Inc.declared on Google Play
Installs4K
Rating2.7423 ratings
Last updatedMay 2025
Legal entityRevian, Inc.declared on Google Play
Installs404
Rating—
Last updatedApr 2026
Legal entityTruLabdeclared on Google Play
Installs184
Rating—
Last updatedJun 2026
Legal entityEpividian, Inc.declared on Google Play
For investors and data teams
Put this intelligence into your own tools
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
Capital & corporate activity
Life sciences funding and M&A across the United States
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Durham compares. Debt, IPO and grant rounds are excluded.
equity rounds, last 12 months360
US$13.54bn
equity rounds, last 24 months1232
US$37.38bn
raised over five yearsUS$157.58bn
5,603 rounds in the United States
M&A deals, the United States1641
last 24 months
Capital by year
amount roundsEquity funding into life sciences in the United States
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
The funding ladder · five years
Rounds and typical cheque by stage
AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years
Most-funded sub-sectors
OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Durham in context
Durham’s share of the United States’s life sciences funding
Equity rounds over the last five years, 217 life sciences companies in Durham among 27,407 in the United States.
Corporate activity · last 24 months
M&A in the United States
1362Acquisition
245Merger
14Takeover
Most active acquirers
- Eli lilly18
- Merck KGaA16
- Novartis15
- Roche AG15
- Na13
Most acquired or merged
- Bluebird bio14
- Teleflex11
- Staar surgical company11
- Exact sciences9
- Terns pharmaceuticals8
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesIndustry landscape report
Life Sciences Industry Landscape of the United States
The financials above are one chapter. The full life sciences landscape of Durham maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
- Market map of every sub-sector
- Funding & company formation by year
- Revenue, profit & financial strength
- Digital footprint: traffic, apps, releases
- Hiring, skills & pay
- Founders & leaders
- News & sentiment
- Where demand runs ahead of supply
Life sciences funding in Durham
69 life sciences companies in Durham have recorded equity funding, US$2.77bn in total. Totals and round dates describe the historical record; they are not current valuations.
Most funded
Largest recorded equity totals, with the latest recorded round.
PulmonologyDeveloper of therapeutics for eosinophilic asthma
Recorded equity fundingUS$435.00mSeries A · Feb 2024
Leadership · 1
Jorge BartolomeCEO
Regenerative medicineProvider of human tissue-based products for vascular disease
Recorded equity fundingUS$424.76mSeries D · Jun 2018
Founder · 1
Juliana BlumCo-Founder, Executive Advisor
OphthalmologyDeveloper of gene therapies for the treatment of ocular diseases
Recorded equity fundingUS$238.00mSeries C · Mar 2025
Founder · 1
Shannon BoyeFounder & Director
GenomicsProvider of services in the development of precision medicine tools for cancer treatment
Recorded equity fundingUS$191.06mSeries D · Nov 2019
Founder · 1
Sizhen WangCo-Founder & CEO
GenomicsProvider of gene editing technology for climate-resilient, nutritious, and sustainable crops
Recorded equity fundingUS$155.00mSeries C · Sep 2024
Leadership · 1
Tom AdamsCEO
Gene therapyDeveloper of gene editing therapies to treat rare genetic diseases
Recorded equity fundingUS$135.65mSeries B · Jun 2018
Leadership · 1
Matthew KaneCEO
Drug deliveryDeveloper of therapeutics to treat cardiopulmonary diseases
Recorded equity fundingUS$126.60mSeries B · Nov 2023
Founder · 1
John PattonFounder
OncologyDeveloper of drug discovery and precision therapy platform for oncology
Recorded equity fundingUS$116.26mSeries B · Apr 2025
Founder · 1
Hans CleversCo-Founder
GenomicsDeveloper of AAV based gene therapies for rare diseases
Recorded equity fundingUS$98.20mSeries B · Mar 2021
Founders · 3
Aravind AsokanCo-Founder
Mavis Agbandje-McKennaCo-Founder & Director
Patrick RitschelCo-Founder
PediatricsProvider of diagnostic products for pediatrics
Recorded equity fundingUS$95.89mSeries C · Sep 2025
Founders · 2
Richard WestCo-Founder & CEO
Vamsee PamulaFounder and President, Board of Directors
Hospital equipmentProvider of rapid infusion system for critically ill patients
Recorded equity fundingUS$65.98mSeries B · Mar 2025
Founder · 1
Mark PiehlCo-Founder & CMO
ImmunotherapyDeveloper of viral vaccines and antibody drug conjugates for the treatment of cancer
Recorded equity fundingUS$48.59mSeries B · Apr 2021
Founders · 2
Matthias GromeierFounder
Darell BignerFounder
ImmunotherapyA next-generation cell cycle control company advancing precision treatments for cancer
Recorded equity fundingUS$46.25mSeries B · Apr 2026
Founders · 4
Patrick RobertsCo-Founder & CEO
Jay StrumCo-Founder
John BisiCo-Founder
Fred EshelmanCo-Founder
ImmunotherapyManufacturer of cytokine agents for treating cancer
Recorded equity fundingUS$45.00mSeries A · Nov 2020
Leadership · 1
Charles NicoletteCEO
OncologyAffordable prescription drugs online, bridging the gap for US customers
Recorded equity fundingUS$42.10mSeries D · Jul 2017
Leadership · 1
Fred EshelmanCEO
PediatricsDeveloper of therapeutic products to treat brain injury in children
Recorded equity fundingUS$37.00mSeries A · Dec 2022
Founders · 2
Eric BennerCo-Founder
Jason KralicCo-Founder
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 19
- Recorded funding
- US$435.00m · Series A · Feb 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Drugs, Copd and asthma, Asthma
Funding over time
US$435.00m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Jorge BartolomeCEO
- Highest education
- Duke University
Investors · 10
- Google VenturesFund
- Marshall WaceFund
- Maverick CapitalFund
- SanofiFund
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers2,338
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 70
- Recorded funding
- US$424.76m · Series D · Jun 2018
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Diversified, Drugs
Funding over time
US$424.76m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Juliana BlumCo-Founder, Executive Advisor
Investors · 7
- Bangkok BankFund
- Pacific EagleFund
- Reignwood GroupFund
- Brady DouganAngel
Team & hiring signals
LinkedIn headcount159201-500
LinkedIn followers16,756
Earlier recorded team702022, a different source
Open roles1of 3 tracked · last posted Mar 2026
Patents
Patent filings137
Focus: Engineered vascular grafts and medicated implantable matrices for blood vessel replacement.
CPC C12N5/0068, A61F2/20, A61L27/3633Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 23 (previous snapshot 49)
- Recorded funding
- US$238.00m · Series C · Mar 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series C
- Focus
- Drugs, Retinal disorders
Funding over time
US$238.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Shannon BoyeFounder & Director
- Highest education
- Doctorates in neuroscience · University Of Florida
Investors · 11
- AbingworthFund
Team & hiring signals
LinkedIn headcount4911-50
LinkedIn followers13,782
Earlier recorded team232022, a different source
Open roles1of 8 tracked · last posted Jun 2026
Recent company signals
- Milestone first patient in Phase 3 pivotal cohort of the LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis (#XLRS) patient doses
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 993
- Recorded funding
- US$191.06m · Series D · Nov 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$191.06m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Sizhen WangCo-Founder & CEO
- Highest education
- Master's of business administration in finance · Ecole Des Hautes Etudes Commerciales
Investors · 11
- AlexandriaFund
- CICCFund
- Share CapitalFund
- V Star CapitalFund
Team & hiring signals
LinkedIn headcount96501-1,000
LinkedIn followers1,189
Earlier recorded team9932022, a different source
Technology
- Nginx
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 163 (previous snapshot 158)
- Recorded funding
- US$155.00m · Series C · Sep 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Applied genomics, Agrigenomics, Farm inputs, Seeds
Funding over time
US$155.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom AdamsCEO
Investors · 6
- Aliment CapitalFund
- DeerfieldFund
- Leaps by BayerFund
- MonsantoFund
- TemasekFund
Team & hiring signals
LinkedIn headcount11551-200
LinkedIn followers18,199
Open roles1of 1 tracked · last posted Jun 2026
- Internship: 2026 Summer Intern
Recent company signals
- Partnership Partnership with Pipewise
Technology
- Cloudflare
- HubSpot
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 236
- Recorded funding
- US$135.65m · Series B · Jun 2018
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$135.65m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Matthew KaneCEO
Investors · 20
- Agent CapitalFund
- Aliment CapitalFund
- BaxterFund
- CowenFund
Team & hiring signals
LinkedIn headcount10051-200
LinkedIn followers24,648
Earlier recorded team2362022, a different source
Open roles1of 1 tracked · last posted Mar 2026
Patents
Patent filings68
Focus: Precise gene editing tools for therapeutic targets and engineered cell therapies
CPC C12N9/22, A61K38/465, C07K14/7151Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 17 (previous snapshot 18)
- Recorded funding
- US$126.60m · Series B · Nov 2023
- Founded
- 2010 · about 16 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Drug delivery, Inhaled
Funding over time
US$126.60m across 12 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John PattonFounder
Investors · 2
- MolexFund
- Molex VenturesFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 72
- Recorded funding
- US$116.26m · Series B · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Funding over time
US$116.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Hans CleversCo-Founder
Investors · 14
- AlexandriaFund
- Alix VenturesFund
- Duke UniversityFund
- EQTFund
- FPV VenturesFund
- Felicis VenturesFund
Team & hiring signals
LinkedIn headcount1051-200
LinkedIn followers7,314
Open roles0of 2 tracked · last posted Jul 2025
Patents
Patent filings97
Focus: Microfluidic organoid droplet generation and component delivery for personalized medicine
CPC B01L3/502784, C12N5/0693, G01N33/5011Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 109 (previous snapshot 120)
- Recorded funding
- US$98.20m · Series B · Mar 2021
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Enabling technologies, Technology platforms
Funding over time
US$98.20m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Aravind AsokanCo-Founder
- Highest education
- Virology · University Of North Carolina At Chapel Hill School Of Medicine
Mavis Agbandje-McKennaCo-Founder & Director
Patrick RitschelCo-Founder
- Highest education
- Bachelor's in mechanical engineering · University Of Illinois At Urbana - Champaign
Investors · 12
- AlexandriaFund
- Novo HoldingsFund
- PontifaxFund
- SareptaFund
Team & hiring signals
LinkedIn headcount451-200
LinkedIn followers5,067
Earlier recorded team1092022, a different source
Patents
Patent filings89
Focus: Recombinant AAV vector design, manufacturing, and gene‑therapy delivery platforms
CPC C12N15/86, C07K14/005, C07K14/47Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 133
- Recorded funding
- US$95.89m · Series C · Sep 2025
- Founded
- 2013 · about 13 years old
- Stage
- Series C
- Focus
- In vitro diagnostic tests, Newborn genetic screening
Funding over time
US$95.89m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Richard WestCo-Founder & CEO
- Highest education
- Doctorates in management · Claremont Graduate University
Vamsee PamulaFounder and President, Board of Directors
Investors · 5
- Duke UniversityFund
Team & hiring signals
LinkedIn headcount7351-200
LinkedIn followers6,898
Earlier recorded team1332022, a different source
Open roles1of 1 tracked · last posted Nov 2025
Patents
Patent filings56
Focus: Rapid microfluidic PCR and point‑of‑care diagnostic platforms for biochemical assays
CPC G01N33/54366, B01L7/525, G01N33/4905Technology
- React
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 33 (previous snapshot 35)
- Recorded funding
- US$65.98m · Series B · Mar 2025
- Founded
- 2012 · about 14 years old
- Stage
- Series B
- Focus
- Critical care, Infusion systems
Funding over time
US$65.98m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mark PiehlCo-Founder & CMO
- Highest education
- Medicine · University Of North Carolina At Chapel Hill School Of Medicine
Investors · 13
- OSF HealthCareFund
- Orlando HealthFund
- WakeMedFund
- WellStarFund
Team & hiring signals
LinkedIn headcount6111-50
LinkedIn followers8,431
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 47 (previous snapshot 56)
- Recorded funding
- US$48.59m · Series B · Apr 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Viral
Funding over time
US$48.59m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Matthias GromeierFounder
Darell BignerFounder
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers3,393
Earlier recorded team472021, a different source
Patents
Patent filings7
Focus: Oncolytic chimeric poliovirus therapies for glioblastoma and intravesical bladder cancer treatment
CPC A61K35/768, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 6 (previous snapshot 6)
- Recorded funding
- US$46.25m · Series B · Apr 2026
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$46.25m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 4
Patrick RobertsCo-Founder & CEO
- Highest education
- The University of North Carolina
Jay StrumCo-Founder
- Highest education
- PhD · Wake Forest University
John BisiCo-Founder
- Highest education
- Bachelor's of Science · NC State University
Fred EshelmanCo-Founder
Investors · 7
- Boxer CapitalFund
- LillyFund
- PharmacosmosFund
Team & hiring signals
LinkedIn headcount132-10
LinkedIn followers1,691
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 47 (previous snapshot 47)
- Recorded funding
- US$45.00m · Series A · Nov 2020
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Leadership · 1
Charles NicoletteCEO
Investors · 1
- Lucio RovatiAngel
Patents
Patent filings55
Focus: Patents concentrated in chemistry & materials
CPC C12N5/0639, G01N33/56972, C12N9/0002Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSocial impact
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 19
- Recorded funding
- US$42.10m · Series D · Jul 2017
- Founded
- 2014 · about 12 years old
- Stage
- Series D
- Focus
- Drugs, Pan cancer
Funding over time
US$42.10m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Fred EshelmanCEO
Investors · 6
- Lilly VenturesFund
- Fred EshelmanAngel
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers341
Earlier recorded team192022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 8 (previous snapshot 10)
- Recorded funding
- US$37.00m · Series A · Dec 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, White matter brain injury
Funding over time
US$37.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Eric BennerCo-Founder
- Highest education
- Duke University School Of Medicine
Jason KralicCo-Founder
- Highest education
- Doctorates in neuroscience · University Of North Carolina At Chapel Hill School Of Medicine
Investors · 1
- XontogenyFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers1,105
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Founders and momentum in Durham
Meet the people behind life sciences companies in Durham. 119 of 146 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Growing teams
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Life sciences techProvider of clinical research and commercialization solutions for healthcare
Team size87,000Up from 586 in the previous snapshot
Founders · 2
Luciano CatoniFounder, Chairman of the Board of Directors
Dennis GillingsFounder
Cad treatment devicesTryton Medical manufactures and sells stent systems for the treatment of bifurcation lesions.
Team size25Up from 16 in the previous snapshot
Founders
Details not available
Healthtech saasEpividian provides novel research services for clinical practice, clinical research, academic, public health, and regulatory purposes.
Team size18Up from 12 in the previous snapshot
Founders
Details not available
Infectious diseasesDeveloper of small molecule based therapeutics for the treatment of recurrent vulvovaginal candidiasis
Team size61Up from 42 in the previous snapshot
Founders
Details not available
GenomicsDeveloper of a predictive breeding platform to identify crop traits and build crop models
Team size24Up from 17 in the previous snapshot
Founders · 2
Spencer MaughanCo-Founder & Chairman
Philip BenfeyCo-Founder & Chairman
OncologyDeveloper of chemo-protective treatments for cancer patients
Team size36Up from 32 in the previous snapshot
Leadership · 1
Rostislav RaykovCEO
Life sciences platforms and toolsProvider of invitro platform for drug testing
Team size29Up from 26 in the previous snapshot
Founders · 5
Scott MagnessCo-Founder
Nancy AllbrittonCo-Founder
Michael BironCo-Founder & CEO
Yuli WangCo-Founder & CSO
Christopher Sims MdFounder, Principle Investigator and Board Member
Life sciences platforms and toolsWhile Bio Products Laboratory (BPL) received its first US FDA approval in 2009, we are part of a global company which boasts a vibrant, 60 year heritage in plasma research, technology and manufacturing.
Team size33Up from 30 in the previous snapshot
Founders
Details not available
Genitourinary disordersDeveloper of hernia mesh devices for treating hernia
Team size12Up from 11 in the previous snapshot
Founder · 1
Howard LevinsonFounder & CMO
Life sciences platforms and toolsDeveloper of a technology to isolate and recover single cells for molecular analysis
Team size28Up from 27 in the previous snapshot
Leadership · 1
Gary PaceCEO
GenomicsProvider of gene editing technology for climate-resilient, nutritious, and sustainable crops
Team size163Up from 158 in the previous snapshot
Leadership · 1
Tom AdamsCEO
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 87,000 (previous snapshot 586)
- Recorded funding
- None recorded
- Founded
- 1982 · about 44 years old
- Stage
- Public
- Focus
- Research & development, Clinical trials, Patient interaction, Industry specific marketing
Founders · 2
Luciano CatoniFounder, Chairman of the Board of Directors
Dennis GillingsFounder
Investors · 1
3i GroupFund
Team & hiring signals
LinkedIn headcount85,80510,001+
LinkedIn followers2,728,991
Earlier recorded team87,0002023, a different source
Recent company signals
- Partnership Partnership with Gaates Medical Research Institute
Patents
Patent filings219
Focus: AI-driven clinical trial data analytics and regulatory intelligence platforms
CPC G16H10/20, G16H10/60, G16H40/20Mobile apps
- IQVIA Study HubHealth & Fitness · 105,417 installs · ★ 3.9 · updated 2026-05-23
- Sales ViewBusiness · 94,435 installs · updated 2022-09-01
- OCEMedical · 11,180 installs · updated 2026-05-20
Technology
- AWS
- Azure
- React
Next.js
Angular
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 25 (previous snapshot 16)
- Recorded funding
- None recorded
- Founded
- 2003 · about 23 years old
- Stage
- Private
- Focus
- Coronary artery diseases, Coronary and peripheral vascular diseases, Implants, Medical devices
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 18 (previous snapshot 12)
- Recorded funding
- None recorded
- Founded
- 2012 · about 14 years old
- Stage
- Private
- Focus
- Ctms and edc, Clinical data management, Clinical trials, Data discovery and visualization
Team & hiring signals
LinkedIn headcount2611-50
LinkedIn followers521
Mobile apps
- Epividian CHORUSHealth & Fitness · 184 installs · updated 2026-06-04
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 61 (previous snapshot 42)
- Recorded funding
- None recorded
- Founded
- 2018 · about 8 years old
- Stage
- Funding Raised
- Focus
- Drugs, Fungal
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers3,587
Technology
- PHP
- MySQL
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 24 (previous snapshot 17)
- Recorded funding
- US$8.50m · Series A · Dec 2018
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Farm inputs, Plant breeding, Management solutions, Analytics
Founders · 2
Spencer MaughanCo-Founder & Chairman
Philip BenfeyCo-Founder & Chairman
- Highest education
- Doctorates in biology · Harvard University
Investors · 7
- GRO AllianceFund
- KdT VenturesFund
- S2G VenturesFund
- Tom FarmsFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers516
Earlier recorded team242021, a different source
Patents
Patent filings37
Focus: Non‑invasive root phenotyping for agricultural plant imaging and phenomics
CPC G01N33/0098, C12Q1/6895, G01N21/84Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 36 (previous snapshot 32)
- Recorded funding
- None recorded
- Founded
- 1996 · about 30 years old
- Stage
- Public
- Focus
- Drugs, Therapy complications, Cisplatin induced hearing loss
Leadership · 1
Rostislav RaykovCEO
Team & hiring signals
LinkedIn headcount5911-50
LinkedIn followers10,442
Earlier recorded team362022, a different source
Open roles1of 1 tracked · last posted Jun 2026
- Hiring: Territory Manager
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 29 (previous snapshot 26)
- Recorded funding
- US$7.53m · Seed · Mar 2025
- Founded
- 2015 · about 11 years old
- Stage
- Seed
- Focus
- Research assays, Cell based assays, Toxicity assays
Funding over time
US$7.53m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 5
Scott MagnessCo-Founder
- Highest education
- BS · University of California San Diego
Nancy AllbrittonCo-Founder
- Highest education
- BS · Louisiana State University
Michael BironCo-Founder & CEO
- Highest education
- MBA · UNC Kenan-Flagler Business School
Yuli WangCo-Founder & CSO
Christopher Sims MdFounder, Principle Investigator and Board Member
- Highest education
- Biology · Uc Irvine
Investors · 5
- RTP CapitalFund
- VentureSouthFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers7,485
Technology
- Cloudflare
- HubSpot
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 33 (previous snapshot 30)
- Recorded funding
- None recorded
- Founded
- Not available
- Stage
- Not available
- Focus
- Diversified, Research services
Team & hiring signals
LinkedIn headcount2855,001-10,000
LinkedIn followers7,839
Recent company signals
- Award Innovate100 Award
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 12 (previous snapshot 11)
- Recorded funding
- US$18.46m · Series A · Sep 2025
- Founded
- 2015 · about 11 years old
- Stage
- Series A
- Focus
- Medical devices, Therapeutics, Hernia
Funding over time
US$18.46m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Howard LevinsonFounder & CMO
Investors · 1
Team & hiring signals
LinkedIn headcount112-10
LinkedIn followers885
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
HardwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 28 (previous snapshot 27)
- Recorded funding
- US$19.10m · Series B · Aug 2023
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Instruments, Cell biology, Cell sorting
Funding over time
US$19.10m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Gary PaceCEO
Investors · 2
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers2,101
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 163 (previous snapshot 158)
- Recorded funding
- US$155.00m · Series C · Sep 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Applied genomics, Agrigenomics, Farm inputs, Seeds
Funding over time
US$155.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom AdamsCEO
Investors · 6
- Aliment CapitalFund
- DeerfieldFund
- Leaps by BayerFund
- MonsantoFund
- TemasekFund
Team & hiring signals
LinkedIn headcount11551-200
LinkedIn followers18,199
Open roles1of 1 tracked · last posted Jun 2026
- Internship: 2026 Summer Intern
Recent company signals
- Partnership Partnership with Pipewise
Technology
- Cloudflare
- HubSpot
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Women-founded
Life sciences companies in Durham with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
GenomicsDeveloper of AAV based gene therapies for rare diseases
Revenue modelSubscription
Founders · 3
Aravind AsokanCo-Founder
Mavis Agbandje-McKennaCo-Founder & Director
Patrick RitschelCo-Founder
Regenerative medicineProvider of human tissue-based products for vascular disease
Revenue modelPhysical commerce
Founder · 1
Juliana BlumCo-Founder, Executive Advisor
Life sciences platforms and toolsProvider of invitro platform for drug testing
Revenue modelPhysical commerce
Founders · 5
Scott MagnessCo-Founder
Nancy AllbrittonCo-Founder
Michael BironCo-Founder & CEO
Yuli WangCo-Founder & CSO
Christopher Sims MdFounder, Principle Investigator and Board Member
Life sciences techCloud based platform to match patients with clinical trials.
Revenue modelSubscription
Founder · 1
Courtney HudsonFounder & CEO
Life sciences techDeveloper of formulation technology for bio-therapeutics drug delivery
Revenue modelPhysical commerce
Founder · 1
Karen LeVertCo-Founder & CEO
OphthalmologyDeveloper of therapies for treating infection, inflammation, and pain
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Laurene WangFounder & CEO
OncologyDeveloper of therapeutic solutions for treating solid tumor brain metastasis
Revenue modelSubscription
Founders · 2
Kimberly BlackwellCo-Founder
Michael ZalutskyCo-Founder
GenomicsProvider of reagents for genomic and epigenetic assays
Revenue modelSubscription
Founders · 3
Samantha PattendenCo-Founder
Joe McMahonCo-Founder & CEO
Paul DaytonCo-Founder
ImmunologySolutions for treatment and management of celiac disease
Revenue modelFee-for-service
Leadership · 1
Jack SyageCEO
NeurologyDeveloper of nanoparticle based drug delivery paltform
Revenue modelE-commerce - product / Subscription
Founder · 1
Afreen AllamFounder & CEO
PediatricsProvider of medical products for postpartum mothers and newborns
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Kristin TullyFounder
OrthopedicsProsthetic and orthotic products
Revenue modelE-commerce - product / Physical commerce
Founders · 2
Marco CalcagnoCo-Founder & President
Brittany StresingCo-Founder & CPO
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 109 (previous snapshot 120)
- Recorded funding
- US$98.20m · Series B · Mar 2021
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Enabling technologies, Technology platforms
Funding over time
US$98.20m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Aravind AsokanCo-Founder
- Highest education
- Virology · University Of North Carolina At Chapel Hill School Of Medicine
Mavis Agbandje-McKennaCo-Founder & Director
Patrick RitschelCo-Founder
- Highest education
- Bachelor's in mechanical engineering · University Of Illinois At Urbana - Champaign
Investors · 12
- AlexandriaFund
- Novo HoldingsFund
- PontifaxFund
- SareptaFund
Team & hiring signals
LinkedIn headcount451-200
LinkedIn followers5,067
Earlier recorded team1092022, a different source
Patents
Patent filings89
Focus: Recombinant AAV vector design, manufacturing, and gene‑therapy delivery platforms
CPC C12N15/86, C07K14/005, C07K14/47Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 70
- Recorded funding
- US$424.76m · Series D · Jun 2018
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Diversified, Drugs
Funding over time
US$424.76m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Juliana BlumCo-Founder, Executive Advisor
Investors · 7
- Bangkok BankFund
- Pacific EagleFund
- Reignwood GroupFund
- Brady DouganAngel
Team & hiring signals
LinkedIn headcount159201-500
LinkedIn followers16,756
Earlier recorded team702022, a different source
Open roles1of 3 tracked · last posted Mar 2026
Patents
Patent filings137
Focus: Engineered vascular grafts and medicated implantable matrices for blood vessel replacement.
CPC C12N5/0068, A61F2/20, A61L27/3633Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 29 (previous snapshot 26)
- Recorded funding
- US$7.53m · Seed · Mar 2025
- Founded
- 2015 · about 11 years old
- Stage
- Seed
- Focus
- Research assays, Cell based assays, Toxicity assays
Funding over time
US$7.53m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 5
Scott MagnessCo-Founder
- Highest education
- BS · University of California San Diego
Nancy AllbrittonCo-Founder
- Highest education
- BS · Louisiana State University
Michael BironCo-Founder & CEO
- Highest education
- MBA · UNC Kenan-Flagler Business School
Yuli WangCo-Founder & CSO
Christopher Sims MdFounder, Principle Investigator and Board Member
- Highest education
- Biology · Uc Irvine
Investors · 5
- RTP CapitalFund
- VentureSouthFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers7,485
Technology
- Cloudflare
- HubSpot
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSaaSSocial impactSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 18)
- Recorded funding
- US$3.00m · Series B · Jan 2006
- Founded
- 2000 · about 26 years old
- Stage
- Series B
- Focus
- Research & development, Clinical trials, Scientific sourcing, Patients
Founders · 1
Courtney HudsonFounder & CEO
- Highest education
- Yale University
Investors · 4
Rand CapitalFund
Spring BayFund
Technology
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 4
- Recorded funding
- US$7.26m · Series B · Mar 2024
- Founded
- 2016 · about 10 years old
- Stage
- Series B
- Focus
- Research & development, Drug formulation
Funding over time
US$7.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Karen LeVertCo-Founder & CEO
- Highest education
- BS · Eastern Michigan University
Investors · 2
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers1,456
Earlier recorded team42019, a different source
Technology
- Google Cloud
- React
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 3
- Recorded funding
- US$200k · Seed · Apr 2017
- Founded
- 2017 · about 9 years old
- Stage
- Seed
- Focus
- Drugs, Diversified
Founders · 1
Laurene WangFounder & CEO
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers423
Earlier recorded team32022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$6.50m · Series A · Jul 2018
- Founded
- 2017 · about 9 years old
- Stage
- Series A
- Focus
- Drugs, Pan cancer
Founders · 2
Kimberly BlackwellCo-Founder
- Highest education
- Duke University
Michael ZalutskyCo-Founder
- Highest education
- Clark University
Investors · 1
Patents
Patent filings7
Focus: HER2-targeted binding molecules for cancer therapy
CPC C07K16/32Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 11 (previous snapshot 11)
- Recorded funding
- None recorded
- Founded
- 2017 · about 9 years old
- Stage
- Funding Raised
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Founders · 3
Samantha PattendenCo-Founder
- Highest education
- Doctorates in molecular biology · University Of Toronto
Joe McMahonCo-Founder & CEO
Paul DaytonCo-Founder
Team & hiring signals
LinkedIn headcount62-10
LinkedIn followers381
Patents
Patent filings18
Focus: Microfluidic sample preparation, nanodroplet-mediated microbial lysis, and biofilm disruption using nanoparticles.
CPC G10K11/30, C12N15/1006, A01N25/28Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 6
- Recorded funding
- None recorded
- Founded
- 2013 · about 13 years old
- Stage
- Funding Raised
- Focus
- Drugs, Diversified
Leadership · 1
Jack SyageCEO
- Highest education
- Ba · Hamilton
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Subscription
- Team size
- 4
- Recorded funding
- None recorded
- Founded
- 2015 · about 11 years old
- Stage
- Funding Raised
- Focus
- Medical devices, Therapeutic devices, Drug delivery
Founders · 1
Afreen AllamFounder & CEO
- Highest education
- Master's of business administration · Duke University - The Fuqua School Of Business
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers304
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 3
- Recorded funding
- None recorded
- Founded
- 2013 · about 13 years old
- Stage
- Funding Raised
- Focus
- Medical devices, Therapeutics, Warmers and incubators
Founders · 1
Kristin TullyFounder
- Highest education
- Doctor of Philosophy · Durham University
Team & hiring signals
LinkedIn headcount122-10
LinkedIn followers1,649
Recent company signals
- Launch Launched Bastinet Care Bassinet (maternity care)
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 2
- Recorded funding
- None recorded
- Founded
- 2013 · about 13 years old
- Stage
- Unfunded
- Focus
- Medical devices, Therapies, Trauma and extremities
Founders · 2
Marco CalcagnoCo-Founder & President
- Highest education
- Bachelor's · Florida International University
Brittany StresingCo-Founder & CPO
Technology
- PHP
- MySQL
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Recently founded
Life sciences companies in Durham founded in the last four years, newest first.
Pain managementDeveloper of non-opioid drugs for neuropathic and eye pain treatment
Founded2024Unfunded
Founders
Details not available
Life sciences techProvider of AI-powered platform for clinical research participant recruitment workflows
Founded2023Seed
Founders · 2
Saathvik BoompelliCo-Founder
John XuCo-Founder
PulmonologyDeveloper of intravascular oxygenation catheter for respiratory failure in hospitals
Founded2023Funding Raised
Founders · 5
Marc DeshussesCo-Founder and Principal Scientist/Engineer
Bruce KlitzmanCo-Founder & Clinical Product Development
Stewart FarlingCo-Founder & Lead Engineer
Tobias StraubeCo-Founder & CMO
Marc DeshussesCo-Founder
OrthopedicsProvider of therapeutics for orthopedic conditions
Founded2023Unfunded
Founders · 2
Shyni VargheseCo-Founder & CTO
Hunter NewmanCo-Founder & CEO
ImmunologyDeveloper of anti-inflammatory and immuno-oncology drugs
Founded2023Unfunded
Founder · 1
Shawn SeongFounder
Cardiac and vascular disordersDeveloper of an implantable medical devices for vascular patients
Founded2023Funding Raised
Leadership · 1
Lora AllemeierCEO
PulmonologyDeveloper of therapeutics for eosinophilic asthma
Founded2022Series A
Leadership · 1
Jorge BartolomeCEO
OrthopedicsDeveloper of solutions for the treatment of orthopedic-related infections
Founded2022Seed
Founders · 2
Jake DonovanCo-Founder and Head of Product Development
Ken GallCo-Founder
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Diversified, Drugs
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial IntelligenceSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$4.30m · Seed · Oct 2025
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Ctms and edc, Clinical trials, Cognitive ai, Conversational ai
Founders · 2
Saathvik BoompelliCo-Founder
- Highest education
- Duke University
John XuCo-Founder
Investors · 8
- Ali RowghaniAngel
- Christophe RimannAngel
- Jack AltmanAngel
- Joshua MillerAngel
- Max CohenAngel
- Sajith WickramasekaraAngel
- Trey HoltermanAngel
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers873
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Funding Raised
- Focus
- Artificial ventilation, Devices, Medical devices, Non invasive ventilation
Founders · 5
Marc DeshussesCo-Founder and Principal Scientist/Engineer
- Highest education
- BS · EPFL
Bruce KlitzmanCo-Founder & Clinical Product Development
- Highest education
- BSc · Duke University
Stewart FarlingCo-Founder & Lead Engineer
Tobias StraubeCo-Founder & CMO
Marc DeshussesCo-Founder
- Highest education
- BS · EPFL
Team & hiring signals
LinkedIn headcount122-10
LinkedIn followers724
Recent company signals
- Award MedTech Innovator's 2025 Value Award — MedTech Innovator
- Award MedTech Innovator Finalist
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Drugs, Diversified
Founders · 2
Shyni VargheseCo-Founder & CTO
Hunter NewmanCo-Founder & CEO
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Unfunded
- Focus
- Drugs, Inflammatory diseases, Diversified, Neurodegenerative
Founders · 1
Shawn SeongFounder
Team & hiring signals
LinkedIn headcount32-10
LinkedIn followers434
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2023 · about 3 years old
- Stage
- Funding Raised
- Focus
- Medical devices, Therapeutic devices, Vascular access and closure
Leadership · 1
Lora AllemeierCEO
- Highest education
- MBA · Kelley
Team & hiring signals
LinkedIn headcount811-50
LinkedIn followers430
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 19
- Recorded funding
- US$435.00m · Series A · Feb 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Drugs, Copd and asthma, Asthma
Funding over time
US$435.00m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Jorge BartolomeCEO
- Highest education
- Duke University
Investors · 10
- Google VenturesFund
- Marshall WaceFund
- Maverick CapitalFund
- SanofiFund
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers2,338
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 5
- Recorded funding
- US$5.09m · Seed · May 2025
- Founded
- 2022 · about 4 years old
- Stage
- Seed
- Focus
- Medical devices, Therapies, Trauma fixation
Funding over time
US$5.09m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Jake DonovanCo-Founder and Head of Product Development
- Highest education
- Master's in management · Duke University
Ken GallCo-Founder
- Highest education
- PhD · University of Illinois
Team & hiring signals
LinkedIn headcount72-10
LinkedIn followers662
Patents
Patent filings3
Focus: Orthopedic intramedullary fixation devices with drug‑eluting coatings for bone healing
CPC A61B17/72, A61L27/44Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Most covered in the news
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
OncologyDeveloper of chemo-protective treatments for cancer patients
News events · last 24 months71Across tracked business press
Leadership · 1
Rostislav RaykovCEO
Rare diseasesDeveloper of small molecule drugs for orphan & autoimmune diseases and antivirals
News events · last 24 months64Across tracked business press
Leadership · 1
Jon StonehouseCEO
Regenerative medicineProvider of human tissue-based products for vascular disease
News events · last 24 months41Across tracked business press
Founder · 1
Juliana BlumCo-Founder, Executive Advisor
OrthopedicsManufacturer of healing therapy products
News events · last 24 months36Across tracked business press
Leadership · 1
Ken RealiCEO
Gene therapyDeveloper of gene therapies to treat retinal degenerative diseases
News events · last 24 months31Across tracked business press
Founder · 1
Jason MenzoCo-Founder
Gene therapyDeveloper of gene editing therapies to treat rare genetic diseases
News events · last 24 months16Across tracked business press
Leadership · 1
Matthew KaneCEO
Life sciences techProvider of clinical research and commercialization solutions for healthcare
News events · last 24 months13Across tracked business press
Founders · 2
Luciano CatoniFounder, Chairman of the Board of Directors
Dennis GillingsFounder
PulmonologyDeveloper of hyperloarized gas MRI for lung imaging
News events · last 24 months12Across tracked business press
Founder · 1
Bastiaan DriehuysFounder
GenomicsProvider of gene editing technology for climate-resilient, nutritious, and sustainable crops
News events · last 24 months10Across tracked business press
Leadership · 1
Tom AdamsCEO
ImmunotherapyRNA particle vaccine technology company developing anti-infective and anti-cancer vaccines
News events · last 24 months7Across tracked business press
Leadership · 1
Peter YoungCEO
Crop techDeveloper of a platform for accelerated crop breeding and evolution
News events · last 24 months4Across tracked business press
Founders · 2
Brendan CollinsCo-Founder
Mariano AlvarezCo-Founder
PulmonologyDeveloper of therapeutics for eosinophilic asthma
News events · last 24 months4Across tracked business press
Leadership · 1
Jorge BartolomeCEO
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 36 (previous snapshot 32)
- Recorded funding
- None recorded
- Founded
- 1996 · about 30 years old
- Stage
- Public
- Focus
- Drugs, Therapy complications, Cisplatin induced hearing loss
Leadership · 1
Rostislav RaykovCEO
Team & hiring signals
LinkedIn headcount5911-50
LinkedIn followers10,442
Earlier recorded team362022, a different source
Open roles1of 1 tracked · last posted Jun 2026
- Hiring: Territory Manager
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Acquirer · 1 deal
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 536
- Recorded funding
- None recorded
- Founded
- 1986 · about 40 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Leadership · 1
Jon StonehouseCEO
- Highest education
- Microbiology · University Of Minnesota
Team & hiring signals
LinkedIn headcount611501-1,000
LinkedIn followers51,911
Earlier recorded team5362024, a different source
Open roles1of 4 tracked · last posted Jun 2026
Technology
- AWS
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 70
- Recorded funding
- US$424.76m · Series D · Jun 2018
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Diversified, Drugs
Funding over time
US$424.76m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Juliana BlumCo-Founder, Executive Advisor
Investors · 7
- Bangkok BankFund
- Pacific EagleFund
- Reignwood GroupFund
- Brady DouganAngel
Team & hiring signals
LinkedIn headcount159201-500
LinkedIn followers16,756
Earlier recorded team702022, a different source
Open roles1of 3 tracked · last posted Mar 2026
Patents
Patent filings137
Focus: Engineered vascular grafts and medicated implantable matrices for blood vessel replacement.
CPC C12N5/0068, A61F2/20, A61L27/3633Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerAcquirer · 1 deal
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 950
- Recorded funding
- None recorded
- Founded
- 2012 · about 14 years old
- Stage
- Public
- Focus
- Diversified, Joint reconstruction, Medical devices, Therapies
Leadership · 1
Ken RealiCEO
Investors · 1
Team & hiring signals
LinkedIn headcount1,170501-1,000
LinkedIn followers52,032
Patents
Patent filings104
Focus: Patents concentrated in chemistry & materials
CPC C01B25/32, A61L27/56, A61N7/00Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14 (previous snapshot 31)
- Recorded funding
- US$23.50m · Seed · Jun 2023
- Founded
- 2021 · about 5 years old
- Stage
- Public
- Focus
- Drugs, Retinal disorders
Funding over time
US$23.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jason MenzoCo-Founder
Investors · 3
- Bios PartnersFund
- RD FundFund
Team & hiring signals
LinkedIn headcount4611-50
LinkedIn followers9,127
Open roles1of 2 tracked · last posted Mar 2026
Patents
Patent filings26
Focus: Pharmaceutical eye‑drop formulations targeting mydriasis, presbyopia, and AMD treatment
CPC A61K31/417, A61K9/0048, C07C57/42Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 236
- Recorded funding
- US$135.65m · Series B · Jun 2018
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$135.65m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Matthew KaneCEO
Investors · 20
- Agent CapitalFund
- Aliment CapitalFund
- BaxterFund
- CowenFund
Team & hiring signals
LinkedIn headcount10051-200
LinkedIn followers24,648
Earlier recorded team2362022, a different source
Open roles1of 1 tracked · last posted Mar 2026
Patents
Patent filings68
Focus: Precise gene editing tools for therapeutic targets and engineered cell therapies
CPC C12N9/22, A61K38/465, C07K14/7151Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 87,000 (previous snapshot 586)
- Recorded funding
- None recorded
- Founded
- 1982 · about 44 years old
- Stage
- Public
- Focus
- Research & development, Clinical trials, Patient interaction, Industry specific marketing
Founders · 2
Luciano CatoniFounder, Chairman of the Board of Directors
Dennis GillingsFounder
Investors · 1
- 3i GroupFund
Team & hiring signals
LinkedIn headcount85,80510,001+
LinkedIn followers2,728,991
Earlier recorded team87,0002023, a different source
Recent company signals
- Partnership Partnership with Gaates Medical Research Institute
Patents
Patent filings219
Focus: AI-driven clinical trial data analytics and regulatory intelligence platforms
CPC G16H10/20, G16H10/60, G16H40/20Mobile apps
- IQVIA Study HubHealth & Fitness · 105,417 installs · ★ 3.9 · updated 2026-05-23
- Sales ViewBusiness · 94,435 installs · updated 2022-09-01
- OCEMedical · 11,180 installs · updated 2026-05-20
Technology
- AWS
- Azure
- React
- Next.js
- Angular
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 28 (previous snapshot 41)
- Recorded funding
- None recorded
- Founded
- 2012 · about 14 years old
- Stage
- Public
- Focus
- Medical devices, Monitoring devices, Image assessment device
Founders · 1
Bastiaan DriehuysFounder
- Highest education
- Princeton University
Team & hiring signals
LinkedIn headcount3111-50
LinkedIn followers4,945
Earlier recorded team282022, a different source
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 163 (previous snapshot 158)
- Recorded funding
- US$155.00m · Series C · Sep 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Applied genomics, Agrigenomics, Farm inputs, Seeds
Funding over time
US$155.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom AdamsCEO
Investors · 6
- Aliment CapitalFund
- DeerfieldFund
- Leaps by BayerFund
- MonsantoFund
- TemasekFund
Team & hiring signals
LinkedIn headcount11551-200
LinkedIn followers18,199
Open roles1of 1 tracked · last posted Jun 2026
- Internship: 2026 Summer Intern
Recent company signals
- Partnership Partnership with Pipewise
Technology
- Cloudflare
- HubSpot
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 9 (previous snapshot 13)
- Recorded funding
- None recorded
- Founded
- 1997 · about 29 years old
- Stage
- Funding Raised
- Focus
- Api production, Cdmo, Diversified, Drugs
Leadership · 1
Peter YoungCEO
Team & hiring signals
LinkedIn headcount951-200
LinkedIn followers985
Patents
Patent filings159
Focus: Production of alphavirus replicon particles for vaccine and gene‑therapy vectors
CPC C12N7/00, C12N15/86, C07K14/005Technology
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial Intelligence
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 10
- Recorded funding
- US$11.25m · Series A · Mar 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Farm inputs, Plant genetic testing, Applied genomics, Agrigenomics
Funding over time
US$11.25m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Brendan CollinsCo-Founder
Mariano AlvarezCo-Founder
- Highest education
- Bachelor's in biology · University Of South Florida
Investors · 11
- AlexandriaFund
- At One VenturesFund
- Better VenturesFund
- Climate CapitalFund
- Germin8 VenturesFund
- IndieBioFund
- SOSVFund
Team & hiring signals
LinkedIn headcount3011-50
LinkedIn followers4,779
Recent company signals
- Partnership Partnership with Seed to System
Patents
Patent filings14
Focus: AI-driven bioinformatics platforms for genomic, gene‑environment and spectral data analysis
CPC G16B20/00, G16B20/20, G06V10/25Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 19
- Recorded funding
- US$435.00m · Series A · Feb 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Drugs, Copd and asthma, Asthma
Funding over time
US$435.00m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Jorge BartolomeCEO
- Highest education
- Duke University
Investors · 10
- Google VenturesFund
- Marshall WaceFund
- Maverick CapitalFund
- SanofiFund
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers2,338
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore Durham life sciences companies by sub-sector
The most common specialisations among life sciences companies in Durham. Open a company to see what it sells, who runs it and how far it has come.
Life sciences tech · 20
20 life sciences companies in Durham work in life sciences tech. Shown: the best-documented.
GenomicsProvider of services in the development of precision medicine tools for cancer treatment
Revenue modelFee-for-service
Founder · 1
Sizhen WangCo-Founder & CEO
Healthcare itProvider of laboratory automation solutions for performing routine tasks in laboratories
Revenue modelSubscription
Founders · 2
Jihoon BaekCo-Founder & CEO
George ZhaoFounder & COO / Head of Product
Life sciences techProvider of chemical compound safety tools for healthcare, cosmetic and food industry
Revenue modelFee-for-service
Leadership · 1
Jean OrelienCEO
Life sciences techCloud based platform to match patients with clinical trials.
Revenue modelSubscription
Founder · 1
Courtney HudsonFounder & CEO
Quantum computingDeveloper of a AI and quantum computing-based drug discovery platform
Revenue modelSubscription
Founder · 1
Bill ShipmanCo-Founder
Life sciences techDeveloper of therapeutics for undruggable targets
Revenue modelPhysical commerce / Subscription
Founders · 4
Mark HallenCo-Founder & CTO
Nancy Miller-RichCo-Founder
Marcel FrenkelCo-Founder & CEO
Bruce DonaldCo-Founder
Life sciences techAI-powered drug discovery and development transforming healthcare with generative AI
Revenue modelFee-for-service
Leadership · 1
Ed AddisonChairman & CEO
Life sciences techDeveloper of formulation technology for bio-therapeutics drug delivery
Revenue modelPhysical commerce
Founder · 1
Karen LeVertCo-Founder & CEO
Life sciences techProvider of AI-powered platform for clinical research participant recruitment workflows
Revenue modelSubscription
Founders · 2
Saathvik BoompelliCo-Founder
John XuCo-Founder
Life sciences techDeveloper of boron-based medicines for various disease conditions
Revenue modelCommission on transaction / E-commerce - product
Leadership · 1
Julie GrantCEO
Life sciences platforms and toolsDeveloper of RNA-modulating small molecule drugs for multiple diseases
Revenue modelSubscription
Founder · 1
Joshua FairbankFounder & CEO
Life sciences techProvider of clinical research and commercialization solutions for healthcare
Revenue modelSubscription
Founders · 2
Luciano CatoniFounder, Chairman of the Board of Directors
Dennis GillingsFounder
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 993
- Recorded funding
- US$191.06m · Series D · Nov 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$191.06m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Sizhen WangCo-Founder & CEO
- Highest education
- Master's of business administration in finance · Ecole Des Hautes Etudes Commerciales
Investors · 11
- AlexandriaFund
- CICCFund
- Share CapitalFund
- V Star CapitalFund
Team & hiring signals
LinkedIn headcount96501-1,000
LinkedIn followers1,189
Earlier recorded team9932022, a different source
Technology
- Nginx
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21
- Recorded funding
- US$4.00m · Seed · Aug 2022
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- Research & development, Laboratory management, Laboratory automation, Pathology
Funding over time
US$4.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Jihoon BaekCo-Founder & CEO
- Highest education
- The University of North Carolina
George ZhaoFounder & COO / Head of Product
Investors · 2
- Tweener FundFund
Team & hiring signals
LinkedIn headcount1811-50
LinkedIn followers1,873
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 15 (previous snapshot 31)
- Recorded funding
- US$90k · Seed · Oct 2020
- Founded
- 2016 · about 10 years old
- Stage
- Seed
- Focus
- Genome informatics, Sequence analysis, Research & development, Drug discovery
Funding over time
US$90k across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Jean OrelienCEO
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers1,469
Earlier recorded team152022, a different source
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSaaSSocial impactSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 18)
- Recorded funding
- US$3.00m · Series B · Jan 2006
- Founded
- 2000 · about 26 years old
- Stage
- Series B
- Focus
- Research & development, Clinical trials, Scientific sourcing, Patients
Founders · 1
Courtney HudsonFounder & CEO
- Highest education
- Yale University
Investors · 4
- Rand CapitalFund
- Spring BayFund
Technology
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 20)
- Recorded funding
- US$2.48m · Seed · Aug 2021
- Founded
- 2019 · about 7 years old
- Stage
- Seed
- Focus
- Applications, Life sciences, Research & development, Drug discovery
Funding over time
US$2.48m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Bill ShipmanCo-Founder
Team & hiring signals
LinkedIn headcount92-10
LinkedIn followers2,018
Earlier recorded team132022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 10 (previous snapshot 10)
- Recorded funding
- US$18.30m · Series A · Feb 2026
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Funding over time
US$18.30m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 4
Mark HallenCo-Founder & CTO
- Highest education
- Bachelor's in mathematics · Duke University
Nancy Miller-RichCo-Founder
Marcel FrenkelCo-Founder & CEO
- Highest education
- Doctorates in biochemistry · Duke University
Bruce DonaldCo-Founder
- Highest education
- Computer Science · Massachusetts Institute Of Technology
Investors · 16
- AlexandriaFund
- Duke UniversityFund
- IndieBioFund
Team & hiring signals
LinkedIn headcount3211-50
LinkedIn followers4,585
Open roles1of 1 tracked · last posted Nov 2025
- Hiring: Principal Scientific Engineer · Dublin, North Carolina
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 5
- Recorded funding
- US$3.35m · Series A · Jul 2015
- Founded
- 2009 · about 17 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics
Funding over time
US$3.35m across 4 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Ed AddisonChairman & CEO
Team & hiring signals
LinkedIn headcount511-50
LinkedIn followers1,228
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 4
- Recorded funding
- US$7.26m · Series B · Mar 2024
- Founded
- 2016 · about 10 years old
- Stage
- Series B
- Focus
- Research & development, Drug formulation
Funding over time
US$7.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Karen LeVertCo-Founder & CEO
- Highest education
- BS · Eastern Michigan University
Investors · 2
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers1,456
Earlier recorded team42019, a different source
Technology
- Google Cloud
- React
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial IntelligenceSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$4.30m · Seed · Oct 2025
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Ctms and edc, Clinical trials, Cognitive ai, Conversational ai
Founders · 2
Saathvik BoompelliCo-Founder
- Highest education
- Duke University
John XuCo-Founder
Investors · 8
- Ali RowghaniAngel
- Christophe RimannAngel
- Jack AltmanAngel
- Joshua MillerAngel
- Max CohenAngel
- Sajith WickramasekaraAngel
- Trey HoltermanAngel
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers873
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, E-commerce - product, Subscription
- Team size
- Not available
- Recorded funding
- US$23.50m · Series A · Sep 2022
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Leadership · 1
Julie GrantCEO
- Highest education
- MBA · Stanford University
Team & hiring signals
LinkedIn headcount211-50
LinkedIn followers467
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$550k · Seed · May 2009
- Founded
- 2009 · about 17 years old
- Stage
- Seed
- Focus
- Research & development, Drug discovery, Genomics, Drug development
Founders · 1
Joshua FairbankFounder & CEO
- Highest education
- Master's of Business Administration · The University of Chicago Booth School of Business
Team & hiring signals
LinkedIn headcount112-10
LinkedIn followers1,053
Patents
Patent filings14
Focus: Provides anti‑flare cookware and grill accessories such as pans, trivet and docking systems.
CPC A47G21/14, B65D1/36, A46B5/0008Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 87,000 (previous snapshot 586)
- Recorded funding
- None recorded
- Founded
- 1982 · about 44 years old
- Stage
- Public
- Focus
- Research & development, Clinical trials, Patient interaction, Industry specific marketing
Founders · 2
Luciano CatoniFounder, Chairman of the Board of Directors
Dennis GillingsFounder
Investors · 1
- 3i GroupFund
Team & hiring signals
LinkedIn headcount85,80510,001+
LinkedIn followers2,728,991
Earlier recorded team87,0002023, a different source
Recent company signals
- Partnership Partnership with Gaates Medical Research Institute
Patents
Patent filings219
Focus: AI-driven clinical trial data analytics and regulatory intelligence platforms
CPC G16H10/20, G16H10/60, G16H40/20Mobile apps
- IQVIA Study HubHealth & Fitness · 105,417 installs · ★ 3.9 · updated 2026-05-23
- Sales ViewBusiness · 94,435 installs · updated 2022-09-01
- OCEMedical · 11,180 installs · updated 2026-05-20
Technology
- AWS
- Azure
- React
- Next.js
- Angular
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences platforms and tools · 18
18 life sciences companies in Durham work in life sciences platforms and tools. Shown: the best-documented.
Life sciences platforms and toolsDevelops assays and research tools for specific biological systems
Revenue modelPhysical commerce / Subscription
Founder · 1
Peyton AndersonFounder & CEO
OncologyDeveloper of drug discovery and precision therapy platform for oncology
Revenue modelSubscription
Founder · 1
Hans CleversCo-Founder
Life sciences platforms and toolsProvider of invitro platform for drug testing
Revenue modelPhysical commerce
Founders · 5
Scott MagnessCo-Founder
Nancy AllbrittonCo-Founder
Michael BironCo-Founder & CEO
Yuli WangCo-Founder & CSO
Christopher Sims MdFounder, Principle Investigator and Board Member
Life sciences platforms and toolsDeveloper of a technology to isolate and recover single cells for molecular analysis
Revenue modelSubscription
Leadership · 1
Gary PaceCEO
Life sciences platforms and toolsDeveloper of a genome sequencing and amplification system
Revenue modelSubscription
Founders · 2
Jay WestCo-Founder & CEO
Charles GawadCo-Founder
Life sciences platforms and toolsProvider and manufacturer of fluorescent dyes for medical diagnostic and imaging systems and tests
Revenue modelPhysical commerce
Leadership · 1
Russell ThomasCEO & President
Life sciences platforms and toolsProvider of multiplexed protein quantification platform for clinical diagnostics and research
Revenue modelPhysical commerce
Founder · 1
David UreChairman & Founder
Life sciences platforms and toolsProvider of data and result information for online lottery games
Revenue modelPhysical commerce
Founder · 1
France AdilFounder & CEO
Life sciences platforms and toolsDeveloper of therapeutic antibodies
Revenue modelPhysical commerce
Founder · 1
Edward PatzCo-Founder & CEO
Life sciences platforms and toolsDeveloper of RNA-modulating small molecule drugs for multiple diseases
Revenue modelSubscription
Founder · 1
Joshua FairbankFounder & CEO
Life sciences platforms and toolsPharmaceutical company specializing in unit dose dry powder inhaler development
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Gilbert MottFounder & CEO & President
Life sciences platforms and toolsWhile Bio Products Laboratory (BPL) received its first US FDA approval in 2009, we are part of a global company which boasts a vibrant, 60 year heritage in plasma research, technology and manufacturing.
Revenue modelPhysical commerce
Founders
Details not available
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 193
- Recorded funding
- US$5.00m · Series B · Mar 2006
- Founded
- 2004 · about 22 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery
Funding over time
US$5.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Peyton AndersonFounder & CEO
- Highest education
- Master's of Business Administration · UNC Kenan-Flagler Business School
Investors · 4
- NC IDEAFund
- Trinity Healthcare DevelopmentFund
Patents
Patent filings97
Focus: Protein diagnostics, peptide-coated device drug delivery, and biomaterial tissue repair technologies.
CPC A61L27/227, A61K47/64, C07K14/001Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 72
- Recorded funding
- US$116.26m · Series B · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Funding over time
US$116.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Hans CleversCo-Founder
Investors · 14
- AlexandriaFund
- Alix VenturesFund
- Duke UniversityFund
- EQTFund
- FPV VenturesFund
- Felicis VenturesFund
Team & hiring signals
LinkedIn headcount1051-200
LinkedIn followers7,314
Open roles0of 2 tracked · last posted Jul 2025
Patents
Patent filings97
Focus: Microfluidic organoid droplet generation and component delivery for personalized medicine
CPC B01L3/502784, C12N5/0693, G01N33/5011Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 29 (previous snapshot 26)
- Recorded funding
- US$7.53m · Seed · Mar 2025
- Founded
- 2015 · about 11 years old
- Stage
- Seed
- Focus
- Research assays, Cell based assays, Toxicity assays
Funding over time
US$7.53m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 5
Scott MagnessCo-Founder
- Highest education
- BS · University of California San Diego
Nancy AllbrittonCo-Founder
- Highest education
- BS · Louisiana State University
Michael BironCo-Founder & CEO
- Highest education
- MBA · UNC Kenan-Flagler Business School
Yuli WangCo-Founder & CSO
Christopher Sims MdFounder, Principle Investigator and Board Member
- Highest education
- Biology · Uc Irvine
Investors · 5
- RTP CapitalFund
- VentureSouthFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers7,485
Technology
- Cloudflare
- HubSpot
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
HardwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 28 (previous snapshot 27)
- Recorded funding
- US$19.10m · Series B · Aug 2023
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Instruments, Cell biology, Cell sorting
Funding over time
US$19.10m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Gary PaceCEO
Investors · 2
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers2,101
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21 (previous snapshot 59)
- Recorded funding
- US$11.50m · Seed · Jan 2020
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- Instruments, Genomics, Nucleic acid sequencing, Enabling technologies
Founders · 2
Jay WestCo-Founder & CEO
Charles GawadCo-Founder
- Highest education
- Doctorates in biology · Stanford University
Investors · 2
- Anzu PartnersFund
Team & hiring signals
LinkedIn headcount4051-200
LinkedIn followers6,305
Earlier recorded team212021, a different source
Recent company signals
- Launch Launched ResolveOMETM Stability Buffer (SB) Reagent (single-cell or low-input multiomic chemistry sample collection and storage)
Patents
Patent filings8
Focus: High‑sensitivity nucleic‑acid amplification and single‑cell genomic analysis technologies
CPC C12Y207/07007, C12Q1/6806, C12Q1/70Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 12 (previous snapshot 12)
- Recorded funding
- US$3.50m · Series A · May 2021
- Founded
- 2013 · about 13 years old
- Stage
- Series A
- Focus
- Research reagents and kits, Probes and dyes, Dyes
Funding over time
US$3.50m across 4 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Russell ThomasCEO & President
- Highest education
- Master's · North Carolina State University
Investors · 1
- ThreeD CapitalFund
Technology
- Nginx
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 11 (previous snapshot 20)
- Recorded funding
- US$13.00m · Series C · Mar 2025
- Founded
- 2006 · about 20 years old
- Stage
- Series C
- Focus
- In-vitro diagnostic tests, Women's cancer, Breast cancer
Funding over time
US$13.00m across 10 disclosed equity rounds
Darker bars = larger roundsFounders · 1
David UreChairman & Founder
Investors · 1
- South Dakota Equity PartnersFund
Team & hiring signals
LinkedIn headcount1511-50
LinkedIn followers583
Patents
Patent filings30
Focus: High-throughput immunoassay platforms for serology and cancer biomarker detection
CPC G01N33/557, G01N33/575, G01N33/57515Technology
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 10 (previous snapshot 12)
- Recorded funding
- US$5.00m · Seed · Mar 2023
- Founded
- 2019 · about 7 years old
- Stage
- Seed
- Focus
- Research services, Diversified, Applied genomics, Agrigenomics
Funding over time
US$5.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
France AdilFounder & CEO
- Highest education
- Master's · Université Claude Bernard Lyon 1
Investors · 12
- 8090 IndustriesFund
- AlexandriaFund
- Cantos VenturesFund
- Climate CapitalFund
- PortfoliaFund
- SFVFund
- SeedFolioFund
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers4,424
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 4 (previous snapshot 6)
- Recorded funding
- US$6.45m · Series B · Dec 2020
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Immuno oncology, Research services
Funding over time
US$6.45m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Edward PatzCo-Founder & CEO
Investors · 4
- Duke UniversityFund
- Jeffery “TJ” HeymanAngel
- Paul FunkAngel
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers615
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$550k · Seed · May 2009
- Founded
- 2009 · about 17 years old
- Stage
- Seed
- Focus
- Research & development, Drug discovery, Genomics, Drug development
Founders · 1
Joshua FairbankFounder & CEO
- Highest education
- Master's of Business Administration · The University of Chicago Booth School of Business
Team & hiring signals
LinkedIn headcount112-10
LinkedIn followers1,053
Patents
Patent filings14
Focus: Provides anti‑flare cookware and grill accessories such as pans, trivet and docking systems.
CPC A47G21/14, B65D1/36, A46B5/0008Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$308k · Seed · Oct 2015
- Founded
- 2010 · about 16 years old
- Stage
- Seed
- Focus
- Inhaled, Research services, Diversified
Founders · 1
Gilbert MottFounder & CEO & President
- Highest education
- Marketing · Ucla Anderson School Of Management
Team & hiring signals
LinkedIn headcount111-50
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 33 (previous snapshot 30)
- Recorded funding
- None recorded
- Founded
- Not available
- Stage
- Not available
- Focus
- Diversified, Research services
Team & hiring signals
LinkedIn headcount2855,001-10,000
LinkedIn followers7,839
Recent company signals
- Award Innovate100 Award
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Genomics · 17
17 life sciences companies in Durham work in genomics. Shown: the best-documented.
GenomicsProvider of services in the development of precision medicine tools for cancer treatment
Revenue modelFee-for-service
Founder · 1
Sizhen WangCo-Founder & CEO
Gene therapyDeveloper of gene editing therapies to treat rare genetic diseases
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
Matthew KaneCEO
GenomicsProvider of gene editing technology for climate-resilient, nutritious, and sustainable crops
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
Tom AdamsCEO
GenomicsDeveloper of AAV based gene therapies for rare diseases
Revenue modelSubscription
Founders · 3
Aravind AsokanCo-Founder
Mavis Agbandje-McKennaCo-Founder & Director
Patrick RitschelCo-Founder
OncologyDeveloper of drug discovery and precision therapy platform for oncology
Revenue modelSubscription
Founder · 1
Hans CleversCo-Founder
GenomicsDeveloper of a predictive breeding platform to identify crop traits and build crop models
Revenue modelPhysical commerce / Subscription
Founders · 2
Spencer MaughanCo-Founder & Chairman
Philip BenfeyCo-Founder & Chairman
Life sciences platforms and toolsDeveloper of a genome sequencing and amplification system
Revenue modelSubscription
Founders · 2
Jay WestCo-Founder & CEO
Charles GawadCo-Founder
GenomicsDeveloper of diagnostics for cancer classification and treatment
Revenue modelSubscription
Founders
Details not available
Clinical genomicsPCR-based Human and Animal testing for vector-borne diseases
Revenue modelSubscription
Leadership · 1
Amanda ElamPresident & CEO
Life sciences techProvider of chemical compound safety tools for healthcare, cosmetic and food industry
Revenue modelFee-for-service
Leadership · 1
Jean OrelienCEO
Crop techDeveloper of a platform for accelerated crop breeding and evolution
Revenue modelSubscription
Founders · 2
Brendan CollinsCo-Founder
Mariano AlvarezCo-Founder
GenomicsProvider of reagents for genomic and epigenetic assays
Revenue modelSubscription
Founders · 3
Samantha PattendenCo-Founder
Joe McMahonCo-Founder & CEO
Paul DaytonCo-Founder
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 993
- Recorded funding
- US$191.06m · Series D · Nov 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$191.06m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Sizhen WangCo-Founder & CEO
- Highest education
- Master's of business administration in finance · Ecole Des Hautes Etudes Commerciales
Investors · 11
- AlexandriaFund
- CICCFund
- Share CapitalFund
- V Star CapitalFund
Team & hiring signals
LinkedIn headcount96501-1,000
LinkedIn followers1,189
Earlier recorded team9932022, a different source
Technology
- Nginx
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 236
- Recorded funding
- US$135.65m · Series B · Jun 2018
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$135.65m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Matthew KaneCEO
Investors · 20
- Agent CapitalFund
- Aliment CapitalFund
- BaxterFund
- CowenFund
Team & hiring signals
LinkedIn headcount10051-200
LinkedIn followers24,648
Earlier recorded team2362022, a different source
Open roles1of 1 tracked · last posted Mar 2026
Patents
Patent filings68
Focus: Precise gene editing tools for therapeutic targets and engineered cell therapies
CPC C12N9/22, A61K38/465, C07K14/7151Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 163 (previous snapshot 158)
- Recorded funding
- US$155.00m · Series C · Sep 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Applied genomics, Agrigenomics, Farm inputs, Seeds
Funding over time
US$155.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom AdamsCEO
Investors · 6
- Aliment CapitalFund
- DeerfieldFund
- Leaps by BayerFund
- MonsantoFund
- TemasekFund
Team & hiring signals
LinkedIn headcount11551-200
LinkedIn followers18,199
Open roles1of 1 tracked · last posted Jun 2026
- Internship: 2026 Summer Intern
Recent company signals
- Partnership Partnership with Pipewise
Technology
- Cloudflare
- HubSpot
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 109 (previous snapshot 120)
- Recorded funding
- US$98.20m · Series B · Mar 2021
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Enabling technologies, Technology platforms
Funding over time
US$98.20m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Aravind AsokanCo-Founder
- Highest education
- Virology · University Of North Carolina At Chapel Hill School Of Medicine
Mavis Agbandje-McKennaCo-Founder & Director
Patrick RitschelCo-Founder
- Highest education
- Bachelor's in mechanical engineering · University Of Illinois At Urbana - Champaign
Investors · 12
- AlexandriaFund
- Novo HoldingsFund
- PontifaxFund
- SareptaFund
Team & hiring signals
LinkedIn headcount451-200
LinkedIn followers5,067
Earlier recorded team1092022, a different source
Patents
Patent filings89
Focus: Recombinant AAV vector design, manufacturing, and gene‑therapy delivery platforms
CPC C12N15/86, C07K14/005, C07K14/47Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 72
- Recorded funding
- US$116.26m · Series B · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Funding over time
US$116.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Hans CleversCo-Founder
Investors · 14
- AlexandriaFund
- Alix VenturesFund
- Duke UniversityFund
- EQTFund
- FPV VenturesFund
- Felicis VenturesFund
Team & hiring signals
LinkedIn headcount1051-200
LinkedIn followers7,314
Open roles0of 2 tracked · last posted Jul 2025
Patents
Patent filings97
Focus: Microfluidic organoid droplet generation and component delivery for personalized medicine
CPC B01L3/502784, C12N5/0693, G01N33/5011Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 24 (previous snapshot 17)
- Recorded funding
- US$8.50m · Series A · Dec 2018
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Farm inputs, Plant breeding, Management solutions, Analytics
Founders · 2
Spencer MaughanCo-Founder & Chairman
Philip BenfeyCo-Founder & Chairman
- Highest education
- Doctorates in biology · Harvard University
Investors · 7
- GRO AllianceFund
- KdT VenturesFund
- S2G VenturesFund
- Tom FarmsFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers516
Earlier recorded team242021, a different source
Patents
Patent filings37
Focus: Non‑invasive root phenotyping for agricultural plant imaging and phenomics
CPC G01N33/0098, C12Q1/6895, G01N21/84Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21 (previous snapshot 59)
- Recorded funding
- US$11.50m · Seed · Jan 2020
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- Instruments, Genomics, Nucleic acid sequencing, Enabling technologies
Founders · 2
Jay WestCo-Founder & CEO
Charles GawadCo-Founder
- Highest education
- Doctorates in biology · Stanford University
Investors · 2
- Anzu PartnersFund
Team & hiring signals
LinkedIn headcount4051-200
LinkedIn followers6,305
Earlier recorded team212021, a different source
Recent company signals
- Launch Launched ResolveOMETM Stability Buffer (SB) Reagent (single-cell or low-input multiomic chemistry sample collection and storage)
Patents
Patent filings8
Focus: High‑sensitivity nucleic‑acid amplification and single‑cell genomic analysis technologies
CPC C12Y207/07007, C12Q1/6806, C12Q1/70Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 22)
- Recorded funding
- US$26.86m · Series C · Jun 2025
- Founded
- 2011 · about 15 years old
- Stage
- Series C
- Focus
- Applied genomics, Clinical genomics, Therapeutics, In-vitro diagnostic tests
Funding over time
US$26.86m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 5
- AlexandriaFund
- LabCorpFund
- Alexandria Venture InvestmentsFund
Team & hiring signals
LinkedIn headcount1411-50
LinkedIn followers2,216
Technology
- PHP
- MySQL
- Cloudflare
- Salesforce
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15 (previous snapshot 21)
- Recorded funding
- US$6.72m · Series A · Apr 2025
- Founded
- 2009 · about 17 years old
- Stage
- Series A
- Focus
- In vitro diagnostic tests, Diversified, Applied genomics, Clinical genomics
Funding over time
US$6.72m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Amanda ElamPresident & CEO
- Highest education
- Doctorates, Sociology · University Of North Carolina At Chapel Hill
Team & hiring signals
LinkedIn headcount2011-50
LinkedIn followers2,132
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 15 (previous snapshot 31)
- Recorded funding
- US$90k · Seed · Oct 2020
- Founded
- 2016 · about 10 years old
- Stage
- Seed
- Focus
- Genome informatics, Sequence analysis, Research & development, Drug discovery
Funding over time
US$90k across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Jean OrelienCEO
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers1,469
Earlier recorded team152022, a different source
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial Intelligence
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 10
- Recorded funding
- US$11.25m · Series A · Mar 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Farm inputs, Plant genetic testing, Applied genomics, Agrigenomics
Funding over time
US$11.25m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Brendan CollinsCo-Founder
Mariano AlvarezCo-Founder
- Highest education
- Bachelor's in biology · University Of South Florida
Investors · 11
- AlexandriaFund
- At One VenturesFund
- Better VenturesFund
- Climate CapitalFund
- Germin8 VenturesFund
- IndieBioFund
- SOSVFund
Team & hiring signals
LinkedIn headcount3011-50
LinkedIn followers4,779
Recent company signals
- Partnership Partnership with Seed to System
Patents
Patent filings14
Focus: AI-driven bioinformatics platforms for genomic, gene‑environment and spectral data analysis
CPC G16B20/00, G16B20/20, G06V10/25Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 11 (previous snapshot 11)
- Recorded funding
- None recorded
- Founded
- 2017 · about 9 years old
- Stage
- Funding Raised
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Founders · 3
Samantha PattendenCo-Founder
- Highest education
- Doctorates in molecular biology · University Of Toronto
Joe McMahonCo-Founder & CEO
Paul DaytonCo-Founder
Team & hiring signals
LinkedIn headcount62-10
LinkedIn followers381
Patents
Patent filings18
Focus: Microfluidic sample preparation, nanodroplet-mediated microbial lysis, and biofilm disruption using nanoparticles.
CPC G10K11/30, C12N15/1006, A01N25/28Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Oncology · 14
14 life sciences companies in Durham work in oncology. Shown: the best-documented.
Gene therapyDeveloper of gene editing therapies to treat rare genetic diseases
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
Matthew KaneCEO
OncologyDeveloper of drug discovery and precision therapy platform for oncology
Revenue modelSubscription
Founder · 1
Hans CleversCo-Founder
ImmunotherapyDeveloper of viral vaccines and antibody drug conjugates for the treatment of cancer
Revenue modelE-commerce - product / Physical commerce
Founders · 2
Matthias GromeierFounder
Darell BignerFounder
ImmunotherapyManufacturer of cytokine agents for treating cancer
Revenue modelFee-for-service
Leadership · 1
Charles NicoletteCEO
GenomicsDeveloper of diagnostics for cancer classification and treatment
Revenue modelSubscription
Founders
Details not available
OncologyAffordable prescription drugs online, bridging the gap for US customers
Revenue modelPhysical commerce
Leadership · 1
Fred EshelmanCEO
ImmunotherapyA next-generation cell cycle control company advancing precision treatments for cancer
Revenue modelPhysical commerce
Founders · 4
Patrick RobertsCo-Founder & CEO
Jay StrumCo-Founder
John BisiCo-Founder
Fred EshelmanCo-Founder
OncologyProvider of polymer-based devices for localized low dose radiation therapy or brachytherapy
Revenue modelPhysical commerce
Leadership · 1
Suzanne BabcockCEO
Life sciences platforms and toolsDeveloper of therapeutic antibodies
Revenue modelPhysical commerce
Founder · 1
Edward PatzCo-Founder & CEO
OncologyDeveloper of therapeutic solutions for treating solid tumor brain metastasis
Revenue modelSubscription
Founders · 2
Kimberly BlackwellCo-Founder
Michael ZalutskyCo-Founder
OncologyDeveloper of chemo-protective treatments for cancer patients
Revenue modelPhysical commerce
Leadership · 1
Rostislav RaykovCEO
ImmunotherapyDeveloper of therapeutics to treat cancer
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
Allen CatoCEO
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 236
- Recorded funding
- US$135.65m · Series B · Jun 2018
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$135.65m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Matthew KaneCEO
Investors · 20
- Agent CapitalFund
- Aliment CapitalFund
- BaxterFund
- CowenFund
Team & hiring signals
LinkedIn headcount10051-200
LinkedIn followers24,648
Earlier recorded team2362022, a different source
Open roles1of 1 tracked · last posted Mar 2026
Patents
Patent filings68
Focus: Precise gene editing tools for therapeutic targets and engineered cell therapies
CPC C12N9/22, A61K38/465, C07K14/7151Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 72
- Recorded funding
- US$116.26m · Series B · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Funding over time
US$116.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Hans CleversCo-Founder
Investors · 14
- AlexandriaFund
- Alix VenturesFund
- Duke UniversityFund
- EQTFund
- FPV VenturesFund
- Felicis VenturesFund
Team & hiring signals
LinkedIn headcount1051-200
LinkedIn followers7,314
Open roles0of 2 tracked · last posted Jul 2025
Patents
Patent filings97
Focus: Microfluidic organoid droplet generation and component delivery for personalized medicine
CPC B01L3/502784, C12N5/0693, G01N33/5011Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 47 (previous snapshot 56)
- Recorded funding
- US$48.59m · Series B · Apr 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Viral
Funding over time
US$48.59m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Matthias GromeierFounder
Darell BignerFounder
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers3,393
Earlier recorded team472021, a different source
Patents
Patent filings7
Focus: Oncolytic chimeric poliovirus therapies for glioblastoma and intravesical bladder cancer treatment
CPC A61K35/768, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 47 (previous snapshot 47)
- Recorded funding
- US$45.00m · Series A · Nov 2020
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Leadership · 1
Charles NicoletteCEO
Investors · 1
- Lucio RovatiAngel
Patents
Patent filings55
Focus: Patents concentrated in chemistry & materials
CPC C12N5/0639, G01N33/56972, C12N9/0002Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 22)
- Recorded funding
- US$26.86m · Series C · Jun 2025
- Founded
- 2011 · about 15 years old
- Stage
- Series C
- Focus
- Applied genomics, Clinical genomics, Therapeutics, In-vitro diagnostic tests
Funding over time
US$26.86m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 5
- AlexandriaFund
- LabCorpFund
- Alexandria Venture InvestmentsFund
Team & hiring signals
LinkedIn headcount1411-50
LinkedIn followers2,216
Technology
- PHP
- MySQL
- Cloudflare
- Salesforce
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSocial impact
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 19
- Recorded funding
- US$42.10m · Series D · Jul 2017
- Founded
- 2014 · about 12 years old
- Stage
- Series D
- Focus
- Drugs, Pan cancer
Funding over time
US$42.10m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Fred EshelmanCEO
Investors · 6
- Lilly VenturesFund
- Fred EshelmanAngel
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers341
Earlier recorded team192022, a different source
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 6 (previous snapshot 6)
- Recorded funding
- US$46.25m · Series B · Apr 2026
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$46.25m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 4
Patrick RobertsCo-Founder & CEO
- Highest education
- The University of North Carolina
Jay StrumCo-Founder
- Highest education
- PhD · Wake Forest University
John BisiCo-Founder
- Highest education
- Bachelor's of Science · NC State University
Fred EshelmanCo-Founder
Investors · 7
- Boxer CapitalFund
- LillyFund
- PharmacosmosFund
Team & hiring signals
LinkedIn headcount132-10
LinkedIn followers1,691
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 6
- Recorded funding
- US$12.40m · Series A · Nov 2021
- Founded
- 2006 · about 20 years old
- Stage
- Series A
- Focus
- Medical devices, Therapies, Radiation therapy, Brachytherapy
Funding over time
US$12.40m across 8 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Suzanne BabcockCEO
Team & hiring signals
LinkedIn headcount511-50
LinkedIn followers513
Patents
Patent filings23
Focus: Microencapsulated, bioabsorbable brachytherapy sources for precise internal radiation therapy
CPC A61N5/1001, A61M37/0069Technology
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 4 (previous snapshot 6)
- Recorded funding
- US$6.45m · Series B · Dec 2020
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Immuno oncology, Research services
Funding over time
US$6.45m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Edward PatzCo-Founder & CEO
Investors · 4
- Duke UniversityFund
- Jeffery “TJ” HeymanAngel
- Paul FunkAngel
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers615
Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$6.50m · Series A · Jul 2018
- Founded
- 2017 · about 9 years old
- Stage
- Series A
- Focus
- Drugs, Pan cancer
Founders · 2
Kimberly BlackwellCo-Founder
- Highest education
- Duke University
Michael ZalutskyCo-Founder
- Highest education
- Clark University
Investors · 1
Patents
Patent filings7
Focus: HER2-targeted binding molecules for cancer therapy
CPC C07K16/32Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 36 (previous snapshot 32)
- Recorded funding
- None recorded
- Founded
- 1996 · about 30 years old
- Stage
- Public
- Focus
- Drugs, Therapy complications, Cisplatin induced hearing loss
Leadership · 1
Rostislav RaykovCEO
Team & hiring signals
LinkedIn headcount5911-50
LinkedIn followers10,442
Earlier recorded team362022, a different source
Open roles1of 1 tracked · last posted Jun 2026
- Hiring: Territory Manager
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 2
- Recorded funding
- None recorded
- Founded
- 2005 · about 21 years old
- Stage
- Funding Raised
- Focus
- Drugs, Diversified
Leadership · 1
Allen CatoCEO
Team & hiring signals
LinkedIn headcount111-50
LinkedIn followers121
Patents
Patent filings59
Focus: Immunotherapy formulations enhancing T‑cell tumor infiltration and cancer vaccine development
CPC C07K7/06, G01N33/6893, A61K39/0011Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore more lists: nearby cities and other sectors in Durham
37 more company lists you can search, plus the Radar directory pages for each place.
Life sciences in nearby cities
- Oakland33 life sciences companiesExplore on Radar
- San Jose110 life sciences companiesExplore on Radar
- Palo Alto165 life sciences companiesExplore on Radar
- Mountain View112 life sciences companiesExplore on Radar
- Santa Clara70 life sciences companiesExplore on Radar
- Sunnyvale123 life sciences companiesExplore on Radar
- San Mateo49 life sciences companiesExplore on Radar
- Redwood City107 life sciences companiesExplore on Radar
- Berkeley109 life sciences companiesExplore on Radar
- Santa Monica35 life sciences companiesExplore on Radar
- San Diego847 life sciences companiesExplore on Radar
- Los Angeles286 life sciences companiesExplore on Radar
Life sciences in other US cities
- New York City665 life sciences companiesExplore on Radar
- Chicago205 life sciences companiesExplore on Radar
- Austin221 life sciences companiesExplore on Radar
- Boston537 life sciences companiesExplore on Radar
- Miami106 life sciences companiesExplore on Radar
- Seattle247 life sciences companiesExplore on Radar
- Denver82 life sciences companiesExplore on Radar
- Atlanta133 life sciences companiesExplore on Radar
- Houston240 life sciences companiesExplore on Radar
- Dallas104 life sciences companiesExplore on Radar
- Philadelphia207 life sciences companiesExplore on Radar
- Washington435 life sciences companiesExplore on Radar
Other sectors in Durham
- Enterprise Applications Companies in Durham, United States 138
- Healthcare Companies in Durham, United States 110
- HealthTech Companies in Durham, United States 99
- Business Services Companies in Durham, United States 90
- Consumer Companies in Durham, United States 66
- Healthcare IT Companies in Durham, United States 52
- Investment Industry Companies in Durham, United States 52
- Education Companies in Durham, United States 45
- High Tech Companies in Durham, United States 44
- Biopharma Outsourcing Companies in Durham, United States 43
- Sustainability Tech Companies in Durham, United States 41
- Retail Companies in Durham, United States 39
- Real Estate and Construction Companies in Durham, United States 36
No list matches. Try a shorter word.